<map:toc-order xmlns:map="http://schema.highwire.org/Journal/Index/Manifest" xml:base="http://sass.highwire.org/bloodjournal/124/21.atom?with-descendants=1&amp;with-descendants-lt=300&amp;with-variant=yes&amp;variant-role=http://schema.highwire.org/variant/manifest" src="manifest">
    <map:group xml:id="PlenaryAbstracts">
        <map:grouping-key>Plenary Abstracts</map:grouping-key>
        <map:display-name>Plenary Abstracts</map:display-name>
        <map:display-name location="toc">Plenary Abstracts</map:display-name>
        <map:group xml:id="PlenaryAbstractsPlenaryScientificSession">
            <map:grouping-key>Plenary Abstracts/Plenary Scientific Session</map:grouping-key>
            <map:display-name>Plenary Scientific Session</map:display-name>
            <map:display-name location="toc">Plenary Scientific Session</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Plenary%20Scientific%20Session&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Plenary%20Scientific%20Session</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
    <map:group xml:id="OralAbstracts">
        <map:grouping-key>Oral Abstracts</map:grouping-key>
        <map:display-name>Oral Abstracts</map:display-name>
        <map:display-name location="toc">Oral Abstracts</map:display-name>
        <map:group xml:id="OralAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIronPathogenicMechanismsAffectingRedCellsErythropoiesis">
            <map:grouping-key>Oral Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Pathogenic Mechanisms Affecting Red Cells &amp; Erythropoiesis</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Pathogenic Mechanisms Affecting Red Cells &amp; Erythropoiesis</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Pathogenic Mechanisms Affecting Red Cells &amp; Erythropoiesis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Pathogenic%20Mechanisms%20Affecting%20Red%20Cells%20%26%20Erythropoiesis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Pathogenic%20Mechanisms%20Affecting%20Red%20Cells%20%26%20Erythropoiesis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIronSystemsBiologyofErythropoiesis">
            <map:grouping-key>Oral Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Systems Biology of Erythropoiesis</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Systems Biology of Erythropoiesis</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Systems Biology of Erythropoiesis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Systems%20Biology%20of%20Erythropoiesis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Systems%20Biology%20of%20Erythropoiesis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts102.RegulationofIronMetabolismIronOverload-NovelMechanismsandTreatments">
            <map:grouping-key>Oral Abstracts/102. Regulation of Iron Metabolism: Iron Overload - Novel Mechanisms and Treatments</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism: Iron Overload - Novel Mechanisms and Treatments</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism: Iron Overload - Novel Mechanisms and Treatments</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism%3A%20Iron%20Overload%20-%20Novel%20Mechanisms%20and%20Treatments&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism%3A%20Iron%20Overload%20-%20Novel%20Mechanisms%20and%20Treatments</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts102.RegulationofIronMetabolismIron-restrictiveAnemias-NewPathwaysandTherapeuticStrategies">
            <map:grouping-key>Oral Abstracts/102. Regulation of Iron Metabolism: Iron-restrictive Anemias - New Pathways and Therapeutic Strategies</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism: Iron-restrictive Anemias - New Pathways and Therapeutic Strategies</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism: Iron-restrictive Anemias - New Pathways and Therapeutic Strategies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism%3A%20Iron-restrictive%20Anemias%20-%20New%20Pathways%20and%20Therapeutic%20Strategies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism%3A%20Iron-restrictive%20Anemias%20-%20New%20Pathways%20and%20Therapeutic%20Strategies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts112.ThalassemiaandGlobinGeneRegulationNoveltherapeuticstrategiesforThalassemia-HbFreactivationandbeyond">
            <map:grouping-key>Oral Abstracts/112. Thalassemia and Globin Gene Regulation: Novel therapeutic strategies for Thalassemia - HbF reactivation and beyond</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation: Novel therapeutic strategies for Thalassemia - HbF reactivation and beyond</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation: Novel therapeutic strategies for Thalassemia - HbF reactivation and beyond</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Novel%20therapeutic%20strategies%20for%20Thalassemia%20-%20HbF%20reactivation%20and%20beyond&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Novel%20therapeutic%20strategies%20for%20Thalassemia%20-%20HbF%20reactivation%20and%20beyond</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts112.ThalassemiaandGlobinGeneRegulationTargetingtheepigenometotreatThalassemia">
            <map:grouping-key>Oral Abstracts/112. Thalassemia and Globin Gene Regulation: Targeting the epigenome to treat Thalassemia</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation: Targeting the epigenome to treat Thalassemia</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation: Targeting the epigenome to treat Thalassemia</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Targeting%20the%20epigenome%20to%20treat%20Thalassemia&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Targeting%20the%20epigenome%20to%20treat%20Thalassemia</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalScienceInnovativeTherapeuticApproachesinSickleCellDisease">
            <map:grouping-key>Oral Abstracts/113. Hemoglobinopathies, Excluding Thalassemia &#150; Basic and Translational Science: Innovative Therapeutic Approaches in Sickle Cell Disease</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia &#150; Basic and Translational Science: Innovative Therapeutic Approaches in Sickle Cell Disease</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia &#150; Basic and Translational Science: Innovative Therapeutic Approaches in Sickle Cell Disease</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%C2%96%20Basic%20and%20Translational%20Science%3A%20Innovative%20Therapeutic%20Approaches%20in%20Sickle%20Cell%20Disease&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%C2%96%20Basic%20and%20Translational%20Science%3A%20Innovative%20Therapeutic%20Approaches%20in%20Sickle%20Cell%20Disease</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalScienceNovelMechanismsofPathogenesisinSickleCellDisease">
            <map:grouping-key>Oral Abstracts/113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Novel Mechanisms of Pathogenesis in Sickle Cell Disease</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Novel Mechanisms of Pathogenesis in Sickle Cell Disease</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Novel Mechanisms of Pathogenesis in Sickle Cell Disease</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Novel%20Mechanisms%20of%20Pathogenesis%20in%20Sickle%20Cell%20Disease&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Novel%20Mechanisms%20of%20Pathogenesis%20in%20Sickle%20Cell%20Disease</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts114.HemoglobinopathiesExcludingThalassemiaClinicalHydroxyureaandNewTherapeutics">
            <map:grouping-key>Oral Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Hydroxyurea and New Therapeutics</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Hydroxyurea and New Therapeutics</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Hydroxyurea and New Therapeutics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Hydroxyurea%20and%20New%20Therapeutics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Hydroxyurea%20and%20New%20Therapeutics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts114.HemoglobinopathiesExcludingThalassemiaClinicalOutcomesandNeuroimaging">
            <map:grouping-key>Oral Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Outcomes and Neuroimaging</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Outcomes and Neuroimaging</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Outcomes and Neuroimaging</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Outcomes%20and%20Neuroimaging&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Outcomes%20and%20Neuroimaging</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts201.GranulocytesMonocytesandMacrophagesMechanismofMyelopoiesis">
            <map:grouping-key>Oral Abstracts/201. Granulocytes, Monocytes and Macrophages: Mechanism of Myelopoiesis</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages: Mechanism of Myelopoiesis</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages: Mechanism of Myelopoiesis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Mechanism%20of%20Myelopoiesis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Mechanism%20of%20Myelopoiesis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts201.GranulocytesMonocytesandMacrophagesMyeloid-MediatedInflammatoryDisorders">
            <map:grouping-key>Oral Abstracts/201. Granulocytes, Monocytes and Macrophages: Myeloid-Mediated Inflammatory Disorders</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages: Myeloid-Mediated Inflammatory Disorders</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages: Myeloid-Mediated Inflammatory Disorders</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Myeloid-Mediated%20Inflammatory%20Disorders&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Myeloid-Mediated%20Inflammatory%20Disorders</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfectionsBcellBiology">
            <map:grouping-key>Oral Abstracts/203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: B cell Biology</map:grouping-key>
            <map:display-name>203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: B cell Biology</map:display-name>
            <map:display-name location="toc">203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: B cell Biology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20B%20cell%20Biology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20B%20cell%20Biology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfectionsNKcellandTcellBiology">
            <map:grouping-key>Oral Abstracts/203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: NK cell and T cell Biology</map:grouping-key>
            <map:display-name>203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: NK cell and T cell Biology</map:display-name>
            <map:display-name location="toc">203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: NK cell and T cell Biology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20NK%20cell%20and%20T%20cell%20Biology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20NK%20cell%20and%20T%20cell%20Biology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts301.PlateletActivationandBiochemistryPlateletandMegakaryocyteBiology">
            <map:grouping-key>Oral Abstracts/301. Platelet Activation and Biochemistry: Platelet and Megakaryocyte Biology</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry: Platelet and Megakaryocyte Biology</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry: Platelet and Megakaryocyte Biology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Platelet%20and%20Megakaryocyte%20Biology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Platelet%20and%20Megakaryocyte%20Biology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts301.PlateletActivationandBiochemistryPlateletsinHemostasisandThrombosis">
            <map:grouping-key>Oral Abstracts/301. Platelet Activation and Biochemistry: Platelets in Hemostasis and Thrombosis</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry: Platelets in Hemostasis and Thrombosis</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry: Platelets in Hemostasis and Thrombosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Platelets%20in%20Hemostasis%20and%20Thrombosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Platelets%20in%20Hemostasis%20and%20Thrombosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts302.VascularWallBiologyEndothelialProgenitorCellsandPlateletAdhesionEndothelialCellsandPlateletsinInfectionInflammationandAngiogenesis">
            <map:grouping-key>Oral Abstracts/302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Endothelial Cells and Platelets in Infection, Inflammation and Angiogenesis</map:grouping-key>
            <map:display-name>302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Endothelial Cells and Platelets in Infection, Inflammation and Angiogenesis</map:display-name>
            <map:display-name location="toc">302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Endothelial Cells and Platelets in Infection, Inflammation and Angiogenesis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Endothelial%20Cells%20and%20Platelets%20in%20Infection%2C%20Inflammation%20and%20Angiogenesis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Endothelial%20Cells%20and%20Platelets%20in%20Infection%2C%20Inflammation%20and%20Angiogenesis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts311.DisordersofPlateletNumberorFunctionClinicalInsightsintoTTPITPandHIT">
            <map:grouping-key>Oral Abstracts/311. Disorders of Platelet Number or Function: Clinical Insights into TTP, ITP and HIT</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: Clinical Insights into TTP, ITP and HIT</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: Clinical Insights into TTP, ITP and HIT</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Clinical%20Insights%20into%20TTP%2C%20ITP%20and%20HIT&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Clinical%20Insights%20into%20TTP%2C%20ITP%20and%20HIT</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts311.DisordersofPlateletNumberorFunctionNewMechanismsinPlateletProductionandFunction">
            <map:grouping-key>Oral Abstracts/311. Disorders of Platelet Number or Function: New Mechanisms in Platelet Production and Function</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: New Mechanisms in Platelet Production and Function</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: New Mechanisms in Platelet Production and Function</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20New%20Mechanisms%20in%20Platelet%20Production%20and%20Function&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20New%20Mechanisms%20in%20Platelet%20Production%20and%20Function</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts311.DisordersofPlateletNumberorFunctionTheEvolvingLandscapeofPlateletClearance">
            <map:grouping-key>Oral Abstracts/311. Disorders of Platelet Number or Function: The Evolving Landscape of Platelet Clearance</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: The Evolving Landscape of Platelet Clearance</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: The Evolving Landscape of Platelet Clearance</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20The%20Evolving%20Landscape%20of%20Platelet%20Clearance&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20The%20Evolving%20Landscape%20of%20Platelet%20Clearance</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts321BloodCoagulationandFibrinolyticFactorsFVIIIHemophiliaandADAMTS13">
            <map:grouping-key>Oral Abstracts/321 Blood Coagulation and Fibrinolytic Factors: FVIII/Hemophilia and ADAMTS13</map:grouping-key>
            <map:display-name>321 Blood Coagulation and Fibrinolytic Factors: FVIII/Hemophilia and ADAMTS13</map:display-name>
            <map:display-name location="toc">321 Blood Coagulation and Fibrinolytic Factors: FVIII/Hemophilia and ADAMTS13</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20FVIII%2FHemophilia%20and%20ADAMTS13&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20FVIII%2FHemophilia%20and%20ADAMTS13</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts321.BloodCoagulationandFibrinolyticFactorsNovelMechanismsandTherapeuticStrategies">
            <map:grouping-key>Oral Abstracts/321. Blood Coagulation and Fibrinolytic Factors: Novel Mechanisms and Therapeutic Strategies</map:grouping-key>
            <map:display-name>321. Blood Coagulation and Fibrinolytic Factors: Novel Mechanisms and Therapeutic Strategies</map:display-name>
            <map:display-name location="toc">321. Blood Coagulation and Fibrinolytic Factors: Novel Mechanisms and Therapeutic Strategies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Novel%20Mechanisms%20and%20Therapeutic%20Strategies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Novel%20Mechanisms%20and%20Therapeutic%20Strategies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts322.DisordersofCoagulationorFibrinolysisComplicationsinHemophilia">
            <map:grouping-key>Oral Abstracts/322. Disorders of Coagulation or Fibrinolysis: Complications in Hemophilia</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis: Complications in Hemophilia</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis: Complications in Hemophilia</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Complications%20in%20Hemophilia&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Complications%20in%20Hemophilia</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts322.DisordersofCoagulationorFibrinolysisInsightsIntovonWillebrandFactor">
            <map:grouping-key>Oral Abstracts/322. Disorders of Coagulation or Fibrinolysis: Insights Into von Willebrand Factor</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis: Insights Into von Willebrand Factor</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis: Insights Into von Willebrand Factor</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Insights%20Into%20von%20Willebrand%20Factor&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Insights%20Into%20von%20Willebrand%20Factor</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts322.DisordersofCoagulationorFibrinolysisNovelHemostaticTherapiesandAssays">
            <map:grouping-key>Oral Abstracts/322. Disorders of Coagulation or Fibrinolysis: Novel Hemostatic Therapies and Assays</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis: Novel Hemostatic Therapies and Assays</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis: Novel Hemostatic Therapies and Assays</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Novel%20Hemostatic%20Therapies%20and%20Assays&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Novel%20Hemostatic%20Therapies%20and%20Assays</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts331.PathophysiologyofThrombosisNovelmechanismsinthrombosis">
            <map:grouping-key>Oral Abstracts/331. Pathophysiology of Thrombosis: Novel mechanisms in thrombosis</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis: Novel mechanisms in thrombosis</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis: Novel mechanisms in thrombosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis%3A%20Novel%20mechanisms%20in%20thrombosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis%3A%20Novel%20mechanisms%20in%20thrombosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts331.PathophysiologyofThrombosisRiskfactorsandbiomarkers">
            <map:grouping-key>Oral Abstracts/331. Pathophysiology of Thrombosis: Risk factors and biomarkers</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis: Risk factors and biomarkers</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis: Risk factors and biomarkers</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis%3A%20Risk%20factors%20and%20biomarkers&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis%3A%20Risk%20factors%20and%20biomarkers</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts332.AntithromboticTherapyAnticoagulantTherapy">
            <map:grouping-key>Oral Abstracts/332. Antithrombotic Therapy: Anticoagulant Therapy</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy: Anticoagulant Therapy</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy: Anticoagulant Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy%3A%20Anticoagulant%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy%3A%20Anticoagulant%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts332.AntithromboticTherapyVenousThromboembolism">
            <map:grouping-key>Oral Abstracts/332. Antithrombotic Therapy: Venous Thromboembolism</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy: Venous Thromboembolism</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy: Venous Thromboembolism</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy%3A%20Venous%20Thromboembolism&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy%3A%20Venous%20Thromboembolism</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusionInfectionInflammationandImmunityinTransfusionMedicine">
            <map:grouping-key>Oral Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion: Infection, Inflammation, and Immunity in Transfusion Medicine</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion: Infection, Inflammation, and Immunity in Transfusion Medicine</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion: Infection, Inflammation, and Immunity in Transfusion Medicine</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Infection%2C%20Inflammation%2C%20and%20Immunity%20in%20Transfusion%20Medicine&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Infection%2C%20Inflammation%2C%20and%20Immunity%20in%20Transfusion%20Medicine</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusionIssuesinRBCTransfusionandMitigationofAlloimmunization">
            <map:grouping-key>Oral Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion: Issues in RBC Transfusion and Mitigation of Alloimmunization</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion: Issues in RBC Transfusion and Mitigation of Alloimmunization</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion: Issues in RBC Transfusion and Mitigation of Alloimmunization</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Issues%20in%20RBC%20Transfusion%20and%20Mitigation%20of%20Alloimmunization&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Issues%20in%20RBC%20Transfusion%20and%20Mitigation%20of%20Alloimmunization</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts501.HematopoieticStemandProgenitorBiologyHSPCGeneticandEpigeneticRegulation">
            <map:grouping-key>Oral Abstracts/501. Hematopoietic Stem and Progenitor Biology: HSPC Genetic and Epigenetic Regulation</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology: HSPC Genetic and Epigenetic Regulation</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology: HSPC Genetic and Epigenetic Regulation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20HSPC%20Genetic%20and%20Epigenetic%20Regulation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20HSPC%20Genetic%20and%20Epigenetic%20Regulation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts501.HematopoieticStemandProgenitorBiologyHSPCStressandSelf-Renewal">
            <map:grouping-key>Oral Abstracts/501. Hematopoietic Stem and Progenitor Biology: HSPC Stress and Self-Renewal</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology: HSPC Stress and Self-Renewal</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology: HSPC Stress and Self-Renewal</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20HSPC%20Stress%20and%20Self-Renewal&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20HSPC%20Stress%20and%20Self-Renewal</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts503.HematopoiesisEpigeneticTranscriptionalandTranslationalControl">
            <map:grouping-key>Oral Abstracts/503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:grouping-key>
            <map:display-name>503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:display-name>
            <map:display-name location="toc">503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts504.HematopoiesisCytokinesSignalTransductionApoptosisandCellCycleRegulationCytokineSignalingInTheHematopoieticNiche">
            <map:grouping-key>Oral Abstracts/504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Cytokine Signaling In The Hematopoietic Niche</map:grouping-key>
            <map:display-name>504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Cytokine Signaling In The Hematopoietic Niche</map:display-name>
            <map:display-name location="toc">504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Cytokine Signaling In The Hematopoietic Niche</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Cytokine%20Signaling%20In%20The%20Hematopoietic%20Niche&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Cytokine%20Signaling%20In%20The%20Hematopoietic%20Niche</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCellsDiversityoftheHematopoieticStemCellNiche">
            <map:grouping-key>Oral Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Diversity of the Hematopoietic Stem Cell Niche</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Diversity of the Hematopoietic Stem Cell Niche</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Diversity of the Hematopoietic Stem Cell Niche</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Diversity%20of%20the%20Hematopoietic%20Stem%20Cell%20Niche&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Diversity%20of%20the%20Hematopoietic%20Stem%20Cell%20Niche</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCellsPathogenicBoneMarrowMicroenvironments">
            <map:grouping-key>Oral Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Pathogenic Bone Marrow Microenvironments</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Pathogenic Bone Marrow Microenvironments</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Pathogenic Bone Marrow Microenvironments</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Pathogenic%20Bone%20Marrow%20Microenvironments&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Pathogenic%20Bone%20Marrow%20Microenvironments</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts508BoneMarrowFailureMolecularMechanismsII">
            <map:grouping-key>Oral Abstracts/508 Bone Marrow Failure: Molecular Mechanisms II</map:grouping-key>
            <map:display-name>508 Bone Marrow Failure: Molecular Mechanisms II</map:display-name>
            <map:display-name location="toc">508 Bone Marrow Failure: Molecular Mechanisms II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508%20Bone%20Marrow%20Failure%3A%20Molecular%20Mechanisms%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508%20Bone%20Marrow%20Failure%3A%20Molecular%20Mechanisms%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts508.BoneMarrowFailureMolecularMechanismsDiagnosisandTreatment">
            <map:grouping-key>Oral Abstracts/508. Bone Marrow Failure: Molecular Mechanisms: Diagnosis and Treatment</map:grouping-key>
            <map:display-name>508. Bone Marrow Failure: Molecular Mechanisms: Diagnosis and Treatment</map:display-name>
            <map:display-name location="toc">508. Bone Marrow Failure: Molecular Mechanisms: Diagnosis and Treatment</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508.%20Bone%20Marrow%20Failure%3A%20Molecular%20Mechanisms%3A%20Diagnosis%20and%20Treatment&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508.%20Bone%20Marrow%20Failure%3A%20Molecular%20Mechanisms%3A%20Diagnosis%20and%20Treatment</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts601.ChromosomalRearrangementsandDNARepairGeneticInstabilityDiagnosisConsequencesandTargetsForTherapy">
            <map:grouping-key>Oral Abstracts/601. Chromosomal Rearrangements and DNA Repair: Genetic Instability: Diagnosis, Consequences, and Targets For Therapy</map:grouping-key>
            <map:display-name>601. Chromosomal Rearrangements and DNA Repair: Genetic Instability: Diagnosis, Consequences, and Targets For Therapy</map:display-name>
            <map:display-name location="toc">601. Chromosomal Rearrangements and DNA Repair: Genetic Instability: Diagnosis, Consequences, and Targets For Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Genetic%20Instability%3A%20Diagnosis%2C%20Consequences%2C%20and%20Targets%20For%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Genetic%20Instability%3A%20Diagnosis%2C%20Consequences%2C%20and%20Targets%20For%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationEpi-GeneticsofLymphoidMalignancy">
            <map:grouping-key>Oral Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: (Epi-)Genetics of Lymphoid Malignancy</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: (Epi-)Genetics of Lymphoid Malignancy</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: (Epi-)Genetics of Lymphoid Malignancy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20%28Epi-%29Genetics%20of%20Lymphoid%20Malignancy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20%28Epi-%29Genetics%20of%20Lymphoid%20Malignancy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationEpigeneticsofHematopoiesisandLeukemia">
            <map:grouping-key>Oral Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Epigenetics of Hematopoiesis and Leukemia</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Epigenetics of Hematopoiesis and Leukemia</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Epigenetics of Hematopoiesis and Leukemia</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Epigenetics%20of%20Hematopoiesis%20and%20Leukemia&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Epigenetics%20of%20Hematopoiesis%20and%20Leukemia</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationMolecularMechanismsofMyeloidMalignancy">
            <map:grouping-key>Oral Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Molecular Mechanisms of Myeloid Malignancy</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Molecular Mechanisms of Myeloid Malignancy</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Molecular Mechanisms of Myeloid Malignancy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Molecular%20Mechanisms%20of%20Myeloid%20Malignancy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Molecular%20Mechanisms%20of%20Myeloid%20Malignancy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts603.OncogenesandTumorSuppressorsNewplayersandpotentialtherapeutictargets">
            <map:grouping-key>Oral Abstracts/603. Oncogenes and Tumor Suppressors: New players and potential therapeutic targets</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: New players and potential therapeutic targets</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: New players and potential therapeutic targets</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20New%20players%20and%20potential%20therapeutic%20targets&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20New%20players%20and%20potential%20therapeutic%20targets</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts603.OncogenesandTumorSuppressorsNovelrolesofclassiconcogenes">
            <map:grouping-key>Oral Abstracts/603. Oncogenes and Tumor Suppressors: Novel roles of 'classic' oncogenes</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: Novel roles of 'classic' oncogenes</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: Novel roles of 'classic' oncogenes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Novel%20roles%20of%20%27classic%27%20oncogenes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Novel%20roles%20of%20%27classic%27%20oncogenes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts603.OncogenesandTumorSuppressorsTheemerginglandscapeofepigeneticmodifiers">
            <map:grouping-key>Oral Abstracts/603. Oncogenes and Tumor Suppressors: The emerging landscape of epigenetic modifiers</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: The emerging landscape of epigenetic modifiers</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: The emerging landscape of epigenetic modifiers</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20The%20emerging%20landscape%20of%20epigenetic%20modifiers&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20The%20emerging%20landscape%20of%20epigenetic%20modifiers</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts604.MolecularPharmacologyandDrugResistanceinMyeloidDiseasesBiologicalPathwaysRelevanttoMolecularPharmacologyandDrugResistanceSensitivity">
            <map:grouping-key>Oral Abstracts/604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Biological Pathways Relevant to Molecular Pharmacology and Drug Resistance/Sensitivity</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Biological Pathways Relevant to Molecular Pharmacology and Drug Resistance/Sensitivity</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Biological Pathways Relevant to Molecular Pharmacology and Drug Resistance/Sensitivity</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Biological%20Pathways%20Relevant%20to%20Molecular%20Pharmacology%20and%20Drug%20Resistance%2FSensitivity&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Biological%20Pathways%20Relevant%20to%20Molecular%20Pharmacology%20and%20Drug%20Resistance%2FSensitivity</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts604.MolecularPharmacologyandDrugResistanceinMyeloidDiseasesMolecularTargetsandDrugSensitivityinMyeloidDiseases">
            <map:grouping-key>Oral Abstracts/604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Molecular Targets and Drug Sensitivity in Myeloid Diseases</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Molecular Targets and Drug Sensitivity in Myeloid Diseases</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Molecular Targets and Drug Sensitivity in Myeloid Diseases</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Molecular%20Targets%20and%20Drug%20Sensitivity%20in%20Myeloid%20Diseases&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Molecular%20Targets%20and%20Drug%20Sensitivity%20in%20Myeloid%20Diseases</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseasesAlternativeTargetsandMechanismofDrugResistanceinLymphomasandMyelomas">
            <map:grouping-key>Oral Abstracts/605. Molecular Pharmacology, Drug Resistance &#150; Lymphoid and Other Diseases: Alternative Targets and Mechanism of Drug Resistance in Lymphomas and Myelomas</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance &#150; Lymphoid and Other Diseases: Alternative Targets and Mechanism of Drug Resistance in Lymphomas and Myelomas</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance &#150; Lymphoid and Other Diseases: Alternative Targets and Mechanism of Drug Resistance in Lymphomas and Myelomas</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%C2%96%20Lymphoid%20and%20Other%20Diseases%3A%20Alternative%20Targets%20and%20Mechanism%20of%20Drug%20Resistance%20in%20Lymphomas%20and%20Myelomas&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%C2%96%20Lymphoid%20and%20Other%20Diseases%3A%20Alternative%20Targets%20and%20Mechanism%20of%20Drug%20Resistance%20in%20Lymphomas%20and%20Myelomas</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseasesNovelTherapeuticTargetsandMechanismsofDrugResistanceinAcuteLymphoblasticLeukemia">
            <map:grouping-key>Oral Abstracts/605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Novel Therapeutic Targets and Mechanisms of Drug Resistance in Acute Lymphoblastic Leukemia</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Novel Therapeutic Targets and Mechanisms of Drug Resistance in Acute Lymphoblastic Leukemia</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Novel Therapeutic Targets and Mechanisms of Drug Resistance in Acute Lymphoblastic Leukemia</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Novel%20Therapeutic%20Targets%20and%20Mechanisms%20of%20Drug%20Resistance%20in%20Acute%20Lymphoblastic%20Leukemia&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Novel%20Therapeutic%20Targets%20and%20Mechanisms%20of%20Drug%20Resistance%20in%20Acute%20Lymphoblastic%20Leukemia</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudiesI">
            <map:grouping-key>Oral Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies I</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies I</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudiesII">
            <map:grouping-key>Oral Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies II</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies II</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesClinicalTrialsandPrognosisI">
            <map:grouping-key>Oral Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis I</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis I</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Clinical%20Trials%20and%20Prognosis%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Clinical%20Trials%20and%20Prognosis%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesClinicalTrialsandPrognosisII">
            <map:grouping-key>Oral Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis II</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis II</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Clinical Trials and Prognosis II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Clinical%20Trials%20and%20Prognosis%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Clinical%20Trials%20and%20Prognosis%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesPathophysiologyandPrognosis">
            <map:grouping-key>Oral Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Pathophysiology and Prognosis</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Pathophysiology and Prognosis</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Pathophysiology and Prognosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Pathophysiology%20and%20Prognosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Pathophysiology%20and%20Prognosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantationAdvancesthroughclinicaltrialsinALL">
            <map:grouping-key>Oral Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Advances through clinical trials in ALL</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Advances through clinical trials in ALL</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Advances through clinical trials in ALL</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Advances%20through%20clinical%20trials%20in%20ALL&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Advances%20through%20clinical%20trials%20in%20ALL</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantationImmunotherapeuticTrialsinALL">
            <map:grouping-key>Oral Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Immunotherapeutic Trials in ALL</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Immunotherapeutic Trials in ALL</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Immunotherapeutic Trials in ALL</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Immunotherapeutic%20Trials%20in%20ALL&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Immunotherapeutic%20Trials%20in%20ALL</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts615.AcuteMyeloidLeukemiaCommerciallyavailableTherapyexcludingTransplantation">
            <map:grouping-key>Oral Abstracts/615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationI">
            <map:grouping-key>Oral Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation I</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation I</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationNewDrugsI">
            <map:grouping-key>Oral Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs I</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs I</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20New%20Drugs%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20New%20Drugs%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationNewDrugsII">
            <map:grouping-key>Oral Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs II</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs II</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20New%20Drugs%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20New%20Drugs%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisEvolutionofGeneticMutationsinAML">
            <map:grouping-key>Oral Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Evolution of Genetic Mutations in AML</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Evolution of Genetic Mutations in AML</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Evolution of Genetic Mutations in AML</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Evolution%20of%20Genetic%20Mutations%20in%20AML&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Evolution%20of%20Genetic%20Mutations%20in%20AML</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisGeneticMutationsinAssociationNovelInsights">
            <map:grouping-key>Oral Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Genetic Mutations in Association: Novel Insights</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Genetic Mutations in Association: Novel Insights</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Genetic Mutations in Association: Novel Insights</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Genetic%20Mutations%20in%20Association%3A%20Novel%20Insights&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Genetic%20Mutations%20in%20Association%3A%20Novel%20Insights</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisInsightsFromNGSAndFunctionalStudies">
            <map:grouping-key>Oral Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Insights From NGS And Functional Studies</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Insights From NGS And Functional Studies</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Insights From NGS And Functional Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Insights%20From%20NGS%20And%20Functional%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Insights%20From%20NGS%20And%20Functional%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisMolecularMarkersandPrognosis">
            <map:grouping-key>Oral Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Molecular Markers and Prognosis</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Molecular Markers and Prognosis</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Molecular Markers and Prognosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Molecular%20Markers%20and%20Prognosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Molecular%20Markers%20and%20Prognosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts618.AcuteLymphoblasticLeukemiaMolecularGeneticStudies">
            <map:grouping-key>Oral Abstracts/618. Acute Lymphoblastic Leukemia: Molecular Genetic Studies</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Molecular Genetic Studies</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Molecular Genetic Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Molecular%20Genetic%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Molecular%20Genetic%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts618.AcuteLymphoblasticLeukemiaPathobiology">
            <map:grouping-key>Oral Abstracts/618. Acute Lymphoblastic Leukemia: Pathobiology</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Pathobiology</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Pathobiology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Pathobiology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Pathobiology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts618.AcuteLymphoblasticLeukemiaPreclinicalModels">
            <map:grouping-key>Oral Abstracts/618. Acute Lymphoblastic Leukemia: Preclinical Models</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Preclinical Models</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Preclinical Models</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Preclinical%20Models&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Preclinical%20Models</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts621.HodgkinLymphomaBiologyExcludingTherapyBiologyandPrognosticMarkers">
            <map:grouping-key>Oral Abstracts/621. Hodgkin Lymphoma: Biology, Excluding Therapy: Biology and Prognostic Markers</map:grouping-key>
            <map:display-name>621. Hodgkin Lymphoma: Biology, Excluding Therapy: Biology and Prognostic Markers</map:display-name>
            <map:display-name location="toc">621. Hodgkin Lymphoma: Biology, Excluding Therapy: Biology and Prognostic Markers</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20Excluding%20Therapy%3A%20Biology%20and%20Prognostic%20Markers&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20Excluding%20Therapy%3A%20Biology%20and%20Prognostic%20Markers</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyI">
            <map:grouping-key>Oral Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy I</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy I</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyII">
            <map:grouping-key>Oral Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy II</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy II</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyGenomic">
            <map:grouping-key>Oral Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Genomic</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Genomic</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Genomic</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Genomic&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Genomic</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyMolecularPathogenesisandPrognosticFactors">
            <map:grouping-key>Oral Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Molecular Pathogenesis and Prognostic Factors</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Molecular Pathogenesis and Prognostic Factors</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Molecular Pathogenesis and Prognostic Factors</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Molecular%20Pathogenesis%20and%20Prognostic%20Factors&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Molecular%20Pathogenesis%20and%20Prognostic%20Factors</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsAdjustingInductionTherapyinLargeCellLymphoma">
            <map:grouping-key>Oral Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Adjusting Induction Therapy in Large Cell Lymphoma</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Adjusting Induction Therapy in Large Cell Lymphoma</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Adjusting Induction Therapy in Large Cell Lymphoma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Adjusting%20Induction%20Therapy%20in%20Large%20Cell%20Lymphoma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Adjusting%20Induction%20Therapy%20in%20Large%20Cell%20Lymphoma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsHodgkinLymphomaT-cellLymphoma">
            <map:grouping-key>Oral Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Hodgkin Lymphoma/ T-cell Lymphoma</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Hodgkin Lymphoma/ T-cell Lymphoma</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Hodgkin Lymphoma/ T-cell Lymphoma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Hodgkin%20Lymphoma%2F%20T-cell%20Lymphoma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Hodgkin%20Lymphoma%2F%20T-cell%20Lymphoma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsIndolentLymphomaandMantleCellLymphoma">
            <map:grouping-key>Oral Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Indolent Lymphoma and Mantle Cell Lymphoma</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Indolent Lymphoma and Mantle Cell Lymphoma</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Indolent Lymphoma and Mantle Cell Lymphoma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Indolent%20Lymphoma%20and%20Mantle%20Cell%20Lymphoma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Indolent%20Lymphoma%20and%20Mantle%20Cell%20Lymphoma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsAggressiveNHL">
            <map:grouping-key>Oral Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Aggressive NHL</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Aggressive NHL</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Aggressive NHL</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Aggressive%20NHL&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Aggressive%20NHL</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsIndolentB-cellNHLandT-cellNHL">
            <map:grouping-key>Oral Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Indolent B-cell NHL and T-cell NHL</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Indolent B-cell NHL and T-cell NHL</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Indolent B-cell NHL and T-cell NHL</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Indolent%20B-cell%20NHL%20and%20T-cell%20NHL&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Indolent%20B-cell%20NHL%20and%20T-cell%20NHL</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsTargetingPD1andCD30inHodgkinLymphomaandNHL">
            <map:grouping-key>Oral Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Targeting PD1 and CD30 in Hodgkin Lymphoma and NHL</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Targeting PD1 and CD30 in Hodgkin Lymphoma and NHL</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Targeting PD1 and CD30 in Hodgkin Lymphoma and NHL</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Targeting%20PD1%20and%20CD30%20in%20Hodgkin%20Lymphoma%20and%20NHL&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Targeting%20PD1%20and%20CD30%20in%20Hodgkin%20Lymphoma%20and%20NHL</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgentsI">
            <map:grouping-key>Oral Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents I</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents I</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgentsII">
            <map:grouping-key>Oral Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents II</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents II</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapyDiseaseProgressionandtheMicroenvironmentTherapeuticImplications">
            <map:grouping-key>Oral Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Disease Progression and the Microenvironment: Therapeutic Implications</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Disease Progression and the Microenvironment: Therapeutic Implications</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Disease Progression and the Microenvironment: Therapeutic Implications</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Disease%20Progression%20and%20the%20Microenvironment%3A%20Therapeutic%20Implications&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Disease%20Progression%20and%20the%20Microenvironment%3A%20Therapeutic%20Implications</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapyStrategiestoCircumventTherapyResistance">
            <map:grouping-key>Oral Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Strategies to Circumvent Therapy Resistance</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Strategies to Circumvent Therapy Resistance</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Strategies to Circumvent Therapy Resistance</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Strategies%20to%20Circumvent%20Therapy%20Resistance&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Strategies%20to%20Circumvent%20Therapy%20Resistance</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts632.ChronicMyeloidLeukemiaOutcomesWithTKITherapy">
            <map:grouping-key>Oral Abstracts/632. Chronic Myeloid Leukemia: Outcomes With TKI Therapy</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Outcomes With TKI Therapy</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Outcomes With TKI Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Outcomes%20With%20TKI%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Outcomes%20With%20TKI%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts632.ChronicMyeloidLeukemiaPrognosisandTherapy">
            <map:grouping-key>Oral Abstracts/632. Chronic Myeloid Leukemia: Prognosis and Therapy</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Prognosis and Therapy</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Prognosis and Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Prognosis%20and%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Prognosis%20and%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts632.ChronicMyeloidLeukemiaTherapyTKIcessationmonitoringandresistance">
            <map:grouping-key>Oral Abstracts/632. Chronic Myeloid Leukemia: Therapy: TKI cessation, monitoring and resistance</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Therapy: TKI cessation, monitoring and resistance</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Therapy: TKI cessation, monitoring and resistance</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20TKI%20cessation%2C%20monitoring%20and%20resistance&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20TKI%20cessation%2C%20monitoring%20and%20resistance</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts634.MyeloproliferativeSyndromesClinicalJAKInhibitorsandTheirCombinations">
            <map:grouping-key>Oral Abstracts/634. Myeloproliferative Syndromes: Clinical: JAK Inhibitors and Their Combinations</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical: JAK Inhibitors and Their Combinations</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical: JAK Inhibitors and Their Combinations</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20JAK%20Inhibitors%20and%20Their%20Combinations&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20JAK%20Inhibitors%20and%20Their%20Combinations</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts634.MyeloproliferativeSyndromesClinicalMutationProfilinginPrognosisandTherapy">
            <map:grouping-key>Oral Abstracts/634. Myeloproliferative Syndromes: Clinical: Mutation Profiling in Prognosis and Therapy</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical: Mutation Profiling in Prognosis and Therapy</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical: Mutation Profiling in Prognosis and Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Mutation%20Profiling%20in%20Prognosis%20and%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Mutation%20Profiling%20in%20Prognosis%20and%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts634.MyeloproliferativeSyndromesClinicalPrognosisOutcomeandNovelTherapies">
            <map:grouping-key>Oral Abstracts/634. Myeloproliferative Syndromes: Clinical: Prognosis, Outcome, and Novel Therapies</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical: Prognosis, Outcome, and Novel Therapies</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical: Prognosis, Outcome, and Novel Therapies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Prognosis%2C%20Outcome%2C%20and%20Novel%20Therapies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Prognosis%2C%20Outcome%2C%20and%20Novel%20Therapies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts635.MyeloproliferativeSyndromesBasicScience-CALREpigeneticModifiersandInhibitorStudies">
            <map:grouping-key>Oral Abstracts/635. Myeloproliferative Syndromes: Basic Science - CALR, Epigenetic Modifiers and Inhibitor Studies</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science - CALR, Epigenetic Modifiers and Inhibitor Studies</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science - CALR, Epigenetic Modifiers and Inhibitor Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%20-%20CALR%2C%20Epigenetic%20Modifiers%20and%20Inhibitor%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%20-%20CALR%2C%20Epigenetic%20Modifiers%20and%20Inhibitor%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts635.MyeloproliferativeSyndromesBasicScience-TranscriptionFactorsandSignaling">
            <map:grouping-key>Oral Abstracts/635. Myeloproliferative Syndromes: Basic Science - Transcription Factors and Signaling</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science - Transcription Factors and Signaling</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science - Transcription Factors and Signaling</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%20-%20Transcription%20Factors%20and%20Signaling&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%20-%20Transcription%20Factors%20and%20Signaling</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudiesGeneticDefectsinMyelodysplasticSyndromes">
            <map:grouping-key>Oral Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies: Genetic Defects in Myelodysplastic Syndromes</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies: Genetic Defects in Myelodysplastic Syndromes</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies: Genetic Defects in Myelodysplastic Syndromes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Genetic%20Defects%20in%20Myelodysplastic%20Syndromes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Genetic%20Defects%20in%20Myelodysplastic%20Syndromes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudiesSpliceosomeGeneMutationsinMyelodysplasticSyndromes">
            <map:grouping-key>Oral Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies: Spliceosome Gene Mutations in Myelodysplastic Syndromes</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies: Spliceosome Gene Mutations in Myelodysplastic Syndromes</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies: Spliceosome Gene Mutations in Myelodysplastic Syndromes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Spliceosome%20Gene%20Mutations%20in%20Myelodysplastic%20Syndromes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Spliceosome%20Gene%20Mutations%20in%20Myelodysplastic%20Syndromes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts637.MyelodysplasticSyndromesClinicalStudiesI">
            <map:grouping-key>Oral Abstracts/637. Myelodysplastic Syndromes – Clinical Studies I</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies I</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts637.MyelodysplasticSyndromesClinicalStudiesClinicalStudiesandDiseaseCharacterization">
            <map:grouping-key>Oral Abstracts/637. Myelodysplastic Syndromes – Clinical Studies: Clinical Studies and Disease Characterization</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies: Clinical Studies and Disease Characterization</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies: Clinical Studies and Disease Characterization</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Clinical%20Studies%20and%20Disease%20Characterization&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Clinical%20Studies%20and%20Disease%20Characterization</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts637.MyelodysplasticSyndromesClinicalStudiesMolecularCharacterizationandLowerRiskMDS">
            <map:grouping-key>Oral Abstracts/637. Myelodysplastic Syndromes – Clinical Studies: Molecular Characterization and Lower Risk MDS</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies: Molecular Characterization and Lower Risk MDS</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies: Molecular Characterization and Lower Risk MDS</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Molecular%20Characterization%20and%20Lower%20Risk%20MDS&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Molecular%20Characterization%20and%20Lower%20Risk%20MDS</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts641.CLLBiologyandPathophysiologyexcludingTherapyAdvancesinImmunogenetics">
            <map:grouping-key>Oral Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy: Advances in (Immuno)genetics</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy: Advances in (Immuno)genetics</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy: Advances in (Immuno)genetics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Advances%20in%20%28Immuno%29genetics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Advances%20in%20%28Immuno%29genetics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts641.CLLBiologyandPathophysiologyexcludingTherapyImmuneinteractionsandCellSignaling">
            <map:grouping-key>Oral Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy: Immune interactions and Cell Signaling</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy: Immune interactions and Cell Signaling</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy: Immune interactions and Cell Signaling</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Immune%20interactions%20and%20Cell%20Signaling&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Immune%20interactions%20and%20Cell%20Signaling</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts641.CLLBiologyandPathophysiologyexcludingTherapyNovelPrognosticatorsandTherapeuticTargets">
            <map:grouping-key>Oral Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy: Novel Prognosticators and Therapeutic Targets</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy: Novel Prognosticators and Therapeutic Targets</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy: Novel Prognosticators and Therapeutic Targets</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Novel%20Prognosticators%20and%20Therapeutic%20Targets&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Novel%20Prognosticators%20and%20Therapeutic%20Targets</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts642.CLLTherapyexcludingTransplantationNovelTherapies">
            <map:grouping-key>Oral Abstracts/642. CLL: Therapy, excluding Transplantation: Novel Therapies</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation: Novel Therapies</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation: Novel Therapies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Novel%20Therapies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Novel%20Therapies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts642.CLLTherapyexcludingTransplantationPhase3TrialsandMore">
            <map:grouping-key>Oral Abstracts/642. CLL: Therapy, excluding Transplantation: Phase 3 Trials and More</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation: Phase 3 Trials and More</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation: Phase 3 Trials and More</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Phase%203%20Trials%20and%20More&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Phase%203%20Trials%20and%20More</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyCellBiologyImmunology">
            <map:grouping-key>Oral Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Cell Biology &amp; Immunology</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Cell Biology &amp; Immunology</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Cell Biology &amp; Immunology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Cell%20Biology%20%26%20Immunology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Cell%20Biology%20%26%20Immunology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyGenomics">
            <map:grouping-key>Oral Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Genomics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Genomics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyMechanismsofDrugResistanceandGenomicInstabilityinMyeloma">
            <map:grouping-key>Oral Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Drug Resistance and Genomic Instability in Myeloma</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Drug Resistance and Genomic Instability in Myeloma</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Drug Resistance and Genomic Instability in Myeloma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Mechanisms%20of%20Drug%20Resistance%20and%20Genomic%20Instability%20in%20Myeloma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Mechanisms%20of%20Drug%20Resistance%20and%20Genomic%20Instability%20in%20Myeloma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyMutationalLandscapeandTranscriptomeEditingPrognosticandPredictiveImpactinMyeloma">
            <map:grouping-key>Oral Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mutational Landscape and Transcriptome Editing: Prognostic and Predictive Impact in Myeloma</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mutational Landscape and Transcriptome Editing: Prognostic and Predictive Impact in Myeloma</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mutational Landscape and Transcriptome Editing: Prognostic and Predictive Impact in Myeloma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Mutational%20Landscape%20and%20Transcriptome%20Editing%3A%20Prognostic%20and%20Predictive%20Impact%20in%20Myeloma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Mutational%20Landscape%20and%20Transcriptome%20Editing%3A%20Prognostic%20and%20Predictive%20Impact%20in%20Myeloma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapySignalTransductioninMyeloma">
            <map:grouping-key>Oral Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Signal Transduction in Myeloma</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Signal Transduction in Myeloma</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Signal Transduction in Myeloma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Signal%20Transduction%20in%20Myeloma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Signal%20Transduction%20in%20Myeloma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapyTargetedTherapiesinMyeloma">
            <map:grouping-key>Oral Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Targeted Therapies in Myeloma</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Targeted Therapies in Myeloma</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Targeted Therapies in Myeloma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Targeted%20Therapies%20in%20Myeloma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Targeted%20Therapies%20in%20Myeloma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts653.MyelomaTherapyexcludingTransplantationI">
            <map:grouping-key>Oral Abstracts/653. Myeloma: Therapy, excluding Transplantation I</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation I</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts653.MyelomaTherapyexcludingTransplantationII">
            <map:grouping-key>Oral Abstracts/653. Myeloma: Therapy, excluding Transplantation II</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation II</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts653.MyelomaTherapyexcludingTransplantationFirstLineTreatments">
            <map:grouping-key>Oral Abstracts/653. Myeloma: Therapy, excluding Transplantation: First Line Treatments</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation: First Line Treatments</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation: First Line Treatments</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20First%20Line%20Treatments&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20First%20Line%20Treatments</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts653.MyelomaTherapyexcludingTransplantationTreatmentsForRelapsedRefractoryDiseaseALAmyloidosis">
            <map:grouping-key>Oral Abstracts/653. Myeloma: Therapy, excluding Transplantation: Treatments For Relapsed/Refractory Disease; AL Amyloidosis</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation: Treatments For Relapsed/Refractory Disease; AL Amyloidosis</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation: Treatments For Relapsed/Refractory Disease; AL Amyloidosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Treatments%20For%20Relapsed%2FRefractory%20Disease%3B%20AL%20Amyloidosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Treatments%20For%20Relapsed%2FRefractory%20Disease%3B%20AL%20Amyloidosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts661.MalignantStemandProgenitorCellsNewInsightsIntoLeukemiaInitiationandProgression">
            <map:grouping-key>Oral Abstracts/661. Malignant Stem and Progenitor Cells : New Insights Into Leukemia Initiation and Progression</map:grouping-key>
            <map:display-name>661. Malignant Stem and Progenitor Cells : New Insights Into Leukemia Initiation and Progression</map:display-name>
            <map:display-name location="toc">661. Malignant Stem and Progenitor Cells : New Insights Into Leukemia Initiation and Progression</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=661.%20Malignant%20Stem%20and%20Progenitor%20Cells%20%3A%20New%20Insights%20Into%20Leukemia%20Initiation%20and%20Progression&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">661.%20Malignant%20Stem%20and%20Progenitor%20Cells%20%3A%20New%20Insights%20Into%20Leukemia%20Initiation%20and%20Progression</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts701.ExperimentalTransplantationBasicBiologyEngraftmentandDiseaseActivity">
            <map:grouping-key>Oral Abstracts/701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:grouping-key>
            <map:display-name>701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:display-name>
            <map:display-name location="toc">701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffectsI">
            <map:grouping-key>Oral Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects I</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects I</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffectsII">
            <map:grouping-key>Oral Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects II</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects II</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts703.AdoptiveImmunotherapyPreclinicalandClinicalResults">
            <map:grouping-key>Oral Abstracts/703. Adoptive Immunotherapy: Preclinical and Clinical Results</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy: Preclinical and Clinical Results</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy: Preclinical and Clinical Results</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy%3A%20Preclinical%20and%20Clinical%20Results&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy%3A%20Preclinical%20and%20Clinical%20Results</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts703.AdoptiveImmunotherapyPreclinicalStudies">
            <map:grouping-key>Oral Abstracts/703. Adoptive Immunotherapy: Preclinical Studies</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy: Preclinical Studies</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy: Preclinical Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy%3A%20Preclinical%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy%3A%20Preclinical%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts711.CellCollectionandProcessingAnsweringClinicalIssues">
            <map:grouping-key>Oral Abstracts/711. Cell Collection and Processing: Answering Clinical Issues</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing: Answering Clinical Issues</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing: Answering Clinical Issues</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing%3A%20Answering%20Clinical%20Issues&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing%3A%20Answering%20Clinical%20Issues</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts711.CellCollectionandProcessingPreclinicalNews">
            <map:grouping-key>Oral Abstracts/711. Cell Collection and Processing: Preclinical News</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing: Preclinical News</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing: Preclinical News</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing%3A%20Preclinical%20News&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing%3A%20Preclinical%20News</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesInfectionsinTransplantRecipients">
            <map:grouping-key>Oral Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Infections in Transplant Recipients</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Infections in Transplant Recipients</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Infections in Transplant Recipients</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Infections%20in%20Transplant%20Recipients&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Infections%20in%20Transplant%20Recipients</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesNovelConditioningRegimens">
            <map:grouping-key>Oral Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Novel Conditioning Regimens</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Novel Conditioning Regimens</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Novel Conditioning Regimens</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Novel%20Conditioning%20Regimens&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Novel%20Conditioning%20Regimens</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesPersonalizingTransplantOutcomes">
            <map:grouping-key>Oral Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Personalizing Transplant Outcomes</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Personalizing Transplant Outcomes</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Personalizing Transplant Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Personalizing%20Transplant%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Personalizing%20Transplant%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionClinicalTrialsinGVHDandImmuneRecovery">
            <map:grouping-key>Oral Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Clinical Trials in GVHD and Immune Recovery</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Clinical Trials in GVHD and Immune Recovery</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Clinical Trials in GVHD and Immune Recovery</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Clinical%20Trials%20in%20GVHD%20and%20Immune%20Recovery&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Clinical%20Trials%20in%20GVHD%20and%20Immune%20Recovery</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionNovelPredictiveBiomarkers">
            <map:grouping-key>Oral Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Novel Predictive Biomarkers</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Novel Predictive Biomarkers</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Novel Predictive Biomarkers</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Novel%20Predictive%20Biomarkers&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Novel%20Predictive%20Biomarkers</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionRiskFactorsforGVHDandOutcomes">
            <map:grouping-key>Oral Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Risk Factors for GVHD and Outcomes</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Risk Factors for GVHD and Outcomes</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Risk Factors for GVHD and Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Risk%20Factors%20for%20GVHD%20and%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Risk%20Factors%20for%20GVHD%20and%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrencePredictingandPreventingDiseaseRecurrence">
            <map:grouping-key>Oral Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Predicting and Preventing Disease Recurrence</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Predicting and Preventing Disease Recurrence</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Predicting and Preventing Disease Recurrence</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Predicting%20and%20Preventing%20Disease%20Recurrence&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Predicting%20and%20Preventing%20Disease%20Recurrence</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrenceTreatmentofDiseaseRecurrenceandLong-termOutcomes">
            <map:grouping-key>Oral Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Treatment of Disease Recurrence and Long-term Outcomes</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Treatment of Disease Recurrence and Long-term Outcomes</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Treatment of Disease Recurrence and Long-term Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Treatment%20of%20Disease%20Recurrence%20and%20Long-term%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Treatment%20of%20Disease%20Recurrence%20and%20Long-term%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts731.ClinicalAutologousTransplantationResultsClinicalResultsinLymphoidMalignancies">
            <map:grouping-key>Oral Abstracts/731. Clinical Autologous Transplantation: Results: Clinical Results in Lymphoid Malignancies</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results: Clinical Results in Lymphoid Malignancies</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results: Clinical Results in Lymphoid Malignancies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Clinical%20Results%20in%20Lymphoid%20Malignancies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Clinical%20Results%20in%20Lymphoid%20Malignancies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts731.ClinicalAutologousTransplantationResultsClinicalResultsinPlasmaCellDyscrasias2">
            <map:grouping-key>Oral Abstracts/731. Clinical Autologous Transplantation: Results: Clinical Results in Plasma Cell Dyscrasias 2</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results: Clinical Results in Plasma Cell Dyscrasias 2</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results: Clinical Results in Plasma Cell Dyscrasias 2</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Clinical%20Results%20in%20Plasma%20Cell%20Dyscrasias%202&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Clinical%20Results%20in%20Plasma%20Cell%20Dyscrasias%202</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts732.ClinicalAllogeneicTransplantationResultsComparativeTransplantationOutcomes">
            <map:grouping-key>Oral Abstracts/732. Clinical Allogeneic Transplantation: Results: Comparative Transplantation Outcomes</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Comparative Transplantation Outcomes</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Comparative Transplantation Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Comparative%20Transplantation%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Comparative%20Transplantation%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts732.ClinicalAllogeneicTransplantationResultsFocusonMyelomaandCordBlood">
            <map:grouping-key>Oral Abstracts/732. Clinical Allogeneic Transplantation: Results: Focus on Myeloma and Cord Blood</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Focus on Myeloma and Cord Blood</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Focus on Myeloma and Cord Blood</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Focus%20on%20Myeloma%20and%20Cord%20Blood&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Focus%20on%20Myeloma%20and%20Cord%20Blood</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts732.ClinicalAllogeneicTransplantationResultsHaploidenticalandBeyond">
            <map:grouping-key>Oral Abstracts/732. Clinical Allogeneic Transplantation: Results: Haploidentical and Beyond</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Haploidentical and Beyond</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Haploidentical and Beyond</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Haploidentical%20and%20Beyond&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Haploidentical%20and%20Beyond</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts732.ClinicalAllogeneicTransplantationResultsImprovingTransplantationOutcomes">
            <map:grouping-key>Oral Abstracts/732. Clinical Allogeneic Transplantation: Results: Improving Transplantation Outcomes</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Improving Transplantation Outcomes</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Improving Transplantation Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Improving%20Transplantation%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Improving%20Transplantation%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts801.GeneTherapyandTransferI">
            <map:grouping-key>Oral Abstracts/801. Gene Therapy and Transfer I</map:grouping-key>
            <map:display-name>801. Gene Therapy and Transfer I</map:display-name>
            <map:display-name location="toc">801. Gene Therapy and Transfer I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=801.%20Gene%20Therapy%20and%20Transfer%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">801.%20Gene%20Therapy%20and%20Transfer%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts802.ChemicalBiologyandExperimentalTherapeuticsIdentificationandPreclinicalEvaluationofNovelGeneticandEpigeneticTargetedTherapies">
            <map:grouping-key>Oral Abstracts/802. Chemical Biology and Experimental Therapeutics: Identification and Preclinical Evaluation of Novel Genetic and Epigenetic Targeted Therapies</map:grouping-key>
            <map:display-name>802. Chemical Biology and Experimental Therapeutics: Identification and Preclinical Evaluation of Novel Genetic and Epigenetic Targeted Therapies</map:display-name>
            <map:display-name location="toc">802. Chemical Biology and Experimental Therapeutics: Identification and Preclinical Evaluation of Novel Genetic and Epigenetic Targeted Therapies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Identification%20and%20Preclinical%20Evaluation%20of%20Novel%20Genetic%20and%20Epigenetic%20Targeted%20Therapies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Identification%20and%20Preclinical%20Evaluation%20of%20Novel%20Genetic%20and%20Epigenetic%20Targeted%20Therapies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsBleedingandClottingDisordersRealWorldOutcomes">
            <map:grouping-key>Oral Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Bleeding and Clotting Disorders: Real World Outcomes</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Bleeding and Clotting Disorders: Real World Outcomes</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Bleeding and Clotting Disorders: Real World Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Bleeding%20and%20Clotting%20Disorders%3A%20Real%20World%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Bleeding%20and%20Clotting%20Disorders%3A%20Real%20World%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsNovelStrategiestoImproveBloodDisorderOutcomes">
            <map:grouping-key>Oral Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Novel Strategies to Improve Blood Disorder Outcomes</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Novel Strategies to Improve Blood Disorder Outcomes</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Novel Strategies to Improve Blood Disorder Outcomes</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Novel%20Strategies%20to%20Improve%20Blood%20Disorder%20Outcomes&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Novel%20Strategies%20to%20Improve%20Blood%20Disorder%20Outcomes</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsSickleCellDiseaseCurrentChallengesandPotentialSolutions">
            <map:grouping-key>Oral Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Sickle Cell Disease: Current Challenges and Potential Solutions</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Sickle Cell Disease: Current Challenges and Potential Solutions</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Sickle Cell Disease: Current Challenges and Potential Solutions</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Sickle%20Cell%20Disease%3A%20Current%20Challenges%20and%20Potential%20Solutions&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Sickle%20Cell%20Disease%3A%20Current%20Challenges%20and%20Potential%20Solutions</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesImpactofPatientReportedOutcomesonSurvivalOutcomesResearchUsingtheFrameworkofClinicalTrialsinMalignantHematology">
            <map:grouping-key>Oral Abstracts/902. Health Services and Outcomes Research &#150; Malignant Diseases: Impact of Patient Reported Outcomes on Survival/Outcomes Research Using the Framework of Clinical Trials in Malignant Hematology</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research &#150; Malignant Diseases: Impact of Patient Reported Outcomes on Survival/Outcomes Research Using the Framework of Clinical Trials in Malignant Hematology</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research &#150; Malignant Diseases: Impact of Patient Reported Outcomes on Survival/Outcomes Research Using the Framework of Clinical Trials in Malignant Hematology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%C2%96%20Malignant%20Diseases%3A%20Impact%20of%20Patient%20Reported%20Outcomes%20on%20Survival%2FOutcomes%20Research%20Using%20the%20Framework%20of%20Clinical%20Trials%20in%20Malignant%20Hematology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%C2%96%20Malignant%20Diseases%3A%20Impact%20of%20Patient%20Reported%20Outcomes%20on%20Survival%2FOutcomes%20Research%20Using%20the%20Framework%20of%20Clinical%20Trials%20in%20Malignant%20Hematology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesHealthServicesResearchinHematologicalMalignanciesUsingPopulationBasedRegistries">
            <map:grouping-key>Oral Abstracts/902. Health Services and Outcomes Research – Malignant Diseases: Health Services Research in Hematological Malignancies Using Population Based Registries</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases: Health Services Research in Hematological Malignancies Using Population Based Registries</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases: Health Services Research in Hematological Malignancies Using Population Based Registries</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Health%20Services%20Research%20in%20Hematological%20Malignancies%20Using%20Population%20Based%20Registries&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Health%20Services%20Research%20in%20Hematological%20Malignancies%20Using%20Population%20Based%20Registries</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesLateEffectsafterTreatmentofHematologicalMalignanciesQualityofCare">
            <map:grouping-key>Oral Abstracts/902. Health Services and Outcomes Research – Malignant Diseases: Late Effects after Treatment of Hematological Malignancies/Quality of Care</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases: Late Effects after Treatment of Hematological Malignancies/Quality of Care</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases: Late Effects after Treatment of Hematological Malignancies/Quality of Care</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Late%20Effects%20after%20Treatment%20of%20Hematological%20Malignancies%2FQuality%20of%20Care&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Late%20Effects%20after%20Treatment%20of%20Hematological%20Malignancies%2FQuality%20of%20Care</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OralAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesNewRefinedPrognosticSchemesPharmacoeconomics">
            <map:grouping-key>Oral Abstracts/902. Health Services and Outcomes Research – Malignant Diseases: New/Refined Prognostic Schemes/Pharmacoeconomics</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases: New/Refined Prognostic Schemes/Pharmacoeconomics</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases: New/Refined Prognostic Schemes/Pharmacoeconomics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20New%2FRefined%20Prognostic%20Schemes%2FPharmacoeconomics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20New%2FRefined%20Prognostic%20Schemes%2FPharmacoeconomics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
    <map:group xml:id="PosterAbstracts">
        <map:grouping-key>Poster Abstracts</map:grouping-key>
        <map:display-name>Poster Abstracts</map:display-name>
        <map:display-name location="toc">Poster Abstracts</map:display-name>
        <map:group xml:id="PosterAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIronPosterI">
            <map:grouping-key>Poster Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIronPosterII">
            <map:grouping-key>Poster Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIronPosterIII">
            <map:grouping-key>Poster Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts102.RegulationofIronMetabolismPosterI">
            <map:grouping-key>Poster Abstracts/102. Regulation of Iron Metabolism: Poster I</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism: Poster I</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts102.RegulationofIronMetabolismPosterII">
            <map:grouping-key>Poster Abstracts/102. Regulation of Iron Metabolism: Poster II</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism: Poster II</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts102.RegulationofIronMetabolismPosterIII">
            <map:grouping-key>Poster Abstracts/102. Regulation of Iron Metabolism: Poster III</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism: Poster III</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts112.ThalassemiaandGlobinGeneRegulationPosterI">
            <map:grouping-key>Poster Abstracts/112. Thalassemia and Globin Gene Regulation: Poster I</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation: Poster I</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts112.ThalassemiaandGlobinGeneRegulationPosterII">
            <map:grouping-key>Poster Abstracts/112. Thalassemia and Globin Gene Regulation: Poster II</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation: Poster II</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts112.ThalassemiaandGlobinGeneRegulationPosterIII">
            <map:grouping-key>Poster Abstracts/112. Thalassemia and Globin Gene Regulation: Poster III</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation: Poster III</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalSciencePosterI">
            <map:grouping-key>Poster Abstracts/113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster I</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster I</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalSciencePosterII">
            <map:grouping-key>Poster Abstracts/113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster II</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster II</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalSciencePosterIII">
            <map:grouping-key>Poster Abstracts/113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster III</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster III</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts114.HemoglobinopathiesExcludingThalassemiaClinicalPosterI">
            <map:grouping-key>Poster Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster I</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster I</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts114.HemoglobinopathiesExcludingThalassemiaClinicalPosterII">
            <map:grouping-key>Poster Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster II</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster II</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts114.HemoglobinopathiesExcludingThalassemiaClinicalPosterIII">
            <map:grouping-key>Poster Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster III</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster III</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts201.GranulocytesMonocytesandMacrophagesPosterI">
            <map:grouping-key>Poster Abstracts/201. Granulocytes, Monocytes and Macrophages: Poster I</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages: Poster I</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts201.GranulocytesMonocytesandMacrophagesPosterII">
            <map:grouping-key>Poster Abstracts/201. Granulocytes, Monocytes and Macrophages: Poster II</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages: Poster II</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts201.GranulocytesMonocytesandMacrophagesPosterIII">
            <map:grouping-key>Poster Abstracts/201. Granulocytes, Monocytes and Macrophages: Poster III</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages: Poster III</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfectionsPosterI">
            <map:grouping-key>Poster Abstracts/203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster I</map:grouping-key>
            <map:display-name>203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster I</map:display-name>
            <map:display-name location="toc">203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfectionsPosterII">
            <map:grouping-key>Poster Abstracts/203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster II</map:grouping-key>
            <map:display-name>203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster II</map:display-name>
            <map:display-name location="toc">203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfectionsPosterIII">
            <map:grouping-key>Poster Abstracts/203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster III</map:grouping-key>
            <map:display-name>203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster III</map:display-name>
            <map:display-name location="toc">203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.%20Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts301.PlateletActivationandBiochemistryPosterI">
            <map:grouping-key>Poster Abstracts/301. Platelet Activation and Biochemistry: Poster I</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry: Poster I</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts301.PlateletActivationandBiochemistryPosterII">
            <map:grouping-key>Poster Abstracts/301. Platelet Activation and Biochemistry: Poster II</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry: Poster II</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts301.PlateletActivationandBiochemistryPosterIII">
            <map:grouping-key>Poster Abstracts/301. Platelet Activation and Biochemistry: Poster III</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry: Poster III</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts302.VascularWallBiologyEndothelialProgenitorCellsandPlateletAdhesionPosterI">
            <map:grouping-key>Poster Abstracts/302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster I</map:grouping-key>
            <map:display-name>302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster I</map:display-name>
            <map:display-name location="toc">302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts302.VascularWallBiologyEndothelialProgenitorCellsandPlateletAdhesionPosterII">
            <map:grouping-key>Poster Abstracts/302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster II</map:grouping-key>
            <map:display-name>302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster II</map:display-name>
            <map:display-name location="toc">302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts302.VascularWallBiologyEndothelialProgenitorCellsandPlateletAdhesionPosterIII">
            <map:grouping-key>Poster Abstracts/302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster III</map:grouping-key>
            <map:display-name>302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster III</map:display-name>
            <map:display-name location="toc">302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts311.DisordersofPlateletNumberorFunctionPosterI">
            <map:grouping-key>Poster Abstracts/311. Disorders of Platelet Number or Function: Poster I</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: Poster I</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts311.DisordersofPlateletNumberorFunctionPosterII">
            <map:grouping-key>Poster Abstracts/311. Disorders of Platelet Number or Function: Poster II</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: Poster II</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts311.DisordersofPlateletNumberorFunctionPosterIII">
            <map:grouping-key>Poster Abstracts/311. Disorders of Platelet Number or Function: Poster III</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function: Poster III</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts321.BloodCoagulationandFibrinolyticFactorsPosterI">
            <map:grouping-key>Poster Abstracts/321. Blood Coagulation and Fibrinolytic Factors: Poster I</map:grouping-key>
            <map:display-name>321. Blood Coagulation and Fibrinolytic Factors: Poster I</map:display-name>
            <map:display-name location="toc">321. Blood Coagulation and Fibrinolytic Factors: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts321.BloodCoagulationandFibrinolyticFactorsPosterII">
            <map:grouping-key>Poster Abstracts/321. Blood Coagulation and Fibrinolytic Factors: Poster II</map:grouping-key>
            <map:display-name>321. Blood Coagulation and Fibrinolytic Factors: Poster II</map:display-name>
            <map:display-name location="toc">321. Blood Coagulation and Fibrinolytic Factors: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts321.BloodCoagulationandFibrinolyticFactorsPosterIII">
            <map:grouping-key>Poster Abstracts/321. Blood Coagulation and Fibrinolytic Factors: Poster III</map:grouping-key>
            <map:display-name>321. Blood Coagulation and Fibrinolytic Factors: Poster III</map:display-name>
            <map:display-name location="toc">321. Blood Coagulation and Fibrinolytic Factors: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts322.DisordersofCoagulationorFibrinolysisPosterI">
            <map:grouping-key>Poster Abstracts/322. Disorders of Coagulation or Fibrinolysis: Poster I</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis: Poster I</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts322.DisordersofCoagulationorFibrinolysisPosterII">
            <map:grouping-key>Poster Abstracts/322. Disorders of Coagulation or Fibrinolysis: Poster II</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis: Poster II</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts331.PathophysiologyofThrombosisPosterI">
            <map:grouping-key>Poster Abstracts/331. Pathophysiology of Thrombosis: Poster I</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis: Poster I</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts331.PathophysiologyofThrombosisPosterII">
            <map:grouping-key>Poster Abstracts/331. Pathophysiology of Thrombosis: Poster II</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis: Poster II</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts331.PathophysiologyofThrombosisPosterIII">
            <map:grouping-key>Poster Abstracts/331. Pathophysiology of Thrombosis: Poster III</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis: Poster III</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts332.AntithromboticTherapyPosterI">
            <map:grouping-key>Poster Abstracts/332. Antithrombotic Therapy: Poster I</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy: Poster I</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts332.AntithromboticTherapyPosterII">
            <map:grouping-key>Poster Abstracts/332. Antithrombotic Therapy: Poster II</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy: Poster II</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts332.AntithromboticTherapyPosterIII">
            <map:grouping-key>Poster Abstracts/332. Antithrombotic Therapy: Poster III</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy: Poster III</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusionPosterI">
            <map:grouping-key>Poster Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion: Poster I</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion: Poster I</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusionPosterII">
            <map:grouping-key>Poster Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion: Poster II</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion: Poster II</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusionPosterIII">
            <map:grouping-key>Poster Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion: Poster III</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion: Poster III</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts501.HematopoieticStemandProgenitorBiologyPosterI">
            <map:grouping-key>Poster Abstracts/501. Hematopoietic Stem and Progenitor Biology: Poster I</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology: Poster I</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts501.HematopoieticStemandProgenitorBiologyPosterII">
            <map:grouping-key>Poster Abstracts/501. Hematopoietic Stem and Progenitor Biology: Poster II</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology: Poster II</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts501.HematopoieticStemandProgenitorBiologyPosterIII">
            <map:grouping-key>Poster Abstracts/501. Hematopoietic Stem and Progenitor Biology: Poster III</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology: Poster III</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts503.HematopoiesisEpigeneticTranscriptionalandTranslationalControlPosterI">
            <map:grouping-key>Poster Abstracts/503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster I</map:grouping-key>
            <map:display-name>503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster I</map:display-name>
            <map:display-name location="toc">503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts503.HematopoiesisEpigeneticTranscriptionalandTranslationalControlPosterII">
            <map:grouping-key>Poster Abstracts/503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster II</map:grouping-key>
            <map:display-name>503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster II</map:display-name>
            <map:display-name location="toc">503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts503.HematopoiesisEpigeneticTranscriptionalandTranslationalControlPosterIII">
            <map:grouping-key>Poster Abstracts/503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster III</map:grouping-key>
            <map:display-name>503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster III</map:display-name>
            <map:display-name location="toc">503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts504.HematopoiesisCytokinesSignalTransductionApoptosisandCellCycleRegulationPosterI">
            <map:grouping-key>Poster Abstracts/504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster I</map:grouping-key>
            <map:display-name>504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster I</map:display-name>
            <map:display-name location="toc">504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts504.HematopoiesisCytokinesSignalTransductionApoptosisandCellCycleRegulationPosterII">
            <map:grouping-key>Poster Abstracts/504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster II</map:grouping-key>
            <map:display-name>504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster II</map:display-name>
            <map:display-name location="toc">504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts504.HematopoiesisCytokinesSignalTransductionApoptosisandCellCycleRegulationPosterIII">
            <map:grouping-key>Poster Abstracts/504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster III</map:grouping-key>
            <map:display-name>504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster III</map:display-name>
            <map:display-name location="toc">504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCellsPosterI">
            <map:grouping-key>Poster Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster I</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster I</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCellsPosterII">
            <map:grouping-key>Poster Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster II</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster II</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCellsPosterIII">
            <map:grouping-key>Poster Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster III</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster III</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts508.BoneMarrowFailurePosterI">
            <map:grouping-key>Poster Abstracts/508. Bone Marrow Failure: Poster I</map:grouping-key>
            <map:display-name>508. Bone Marrow Failure: Poster I</map:display-name>
            <map:display-name location="toc">508. Bone Marrow Failure: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508.%20Bone%20Marrow%20Failure%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508.%20Bone%20Marrow%20Failure%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts508.BoneMarrowFailurePosterII">
            <map:grouping-key>Poster Abstracts/508. Bone Marrow Failure: Poster II</map:grouping-key>
            <map:display-name>508. Bone Marrow Failure: Poster II</map:display-name>
            <map:display-name location="toc">508. Bone Marrow Failure: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508.%20Bone%20Marrow%20Failure%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508.%20Bone%20Marrow%20Failure%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts508.BoneMarrowFailurePosterIII">
            <map:grouping-key>Poster Abstracts/508. Bone Marrow Failure: Poster III</map:grouping-key>
            <map:display-name>508. Bone Marrow Failure: Poster III</map:display-name>
            <map:display-name location="toc">508. Bone Marrow Failure: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508.%20Bone%20Marrow%20Failure%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508.%20Bone%20Marrow%20Failure%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts601.ChromosomalRearrangementsandDNARepairPosterI">
            <map:grouping-key>Poster Abstracts/601. Chromosomal Rearrangements and DNA Repair: Poster I</map:grouping-key>
            <map:display-name>601. Chromosomal Rearrangements and DNA Repair: Poster I</map:display-name>
            <map:display-name location="toc">601. Chromosomal Rearrangements and DNA Repair: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts601.ChromosomalRearrangementsandDNARepairPosterII">
            <map:grouping-key>Poster Abstracts/601. Chromosomal Rearrangements and DNA Repair: Poster II</map:grouping-key>
            <map:display-name>601. Chromosomal Rearrangements and DNA Repair: Poster II</map:display-name>
            <map:display-name location="toc">601. Chromosomal Rearrangements and DNA Repair: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationPosterI">
            <map:grouping-key>Poster Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationPosterII">
            <map:grouping-key>Poster Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulationPosterIII">
            <map:grouping-key>Poster Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts603.OncogenesandTumorSuppressorsPosterI">
            <map:grouping-key>Poster Abstracts/603. Oncogenes and Tumor Suppressors: Poster I</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: Poster I</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts603.OncogenesandTumorSuppressorsPosterII">
            <map:grouping-key>Poster Abstracts/603. Oncogenes and Tumor Suppressors: Poster II</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: Poster II</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts603.OncogenesandTumorSuppressorsPosterIII">
            <map:grouping-key>Poster Abstracts/603. Oncogenes and Tumor Suppressors: Poster III</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors: Poster III</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts604.MolecularPharmacologyandDrugResistanceinMyeloidDiseasesPosterI">
            <map:grouping-key>Poster Abstracts/604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts604.MolecularPharmacologyandDrugResistanceinMyeloidDiseasesPosterII">
            <map:grouping-key>Poster Abstracts/604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts604.MolecularPharmacologyandDrugResistanceinMyeloidDiseasesPosterIII">
            <map:grouping-key>Poster Abstracts/604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%20and%20Drug%20Resistance%20in%20Myeloid%20Diseases%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseasesPosterI">
            <map:grouping-key>Poster Abstracts/605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster I</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster I</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseasesPosterII">
            <map:grouping-key>Poster Abstracts/605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster II</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster II</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseasesPosterIII">
            <map:grouping-key>Poster Abstracts/605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster III</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster III</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudiesPosterI">
            <map:grouping-key>Poster Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudiesPosterII">
            <map:grouping-key>Poster Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudiesPosterIII">
            <map:grouping-key>Poster Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster III</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster III</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesPosterI">
            <map:grouping-key>Poster Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Poster I</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Poster I</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesPosterII">
            <map:grouping-key>Poster Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Poster II</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Poster II</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts613.AcuteMyeloidLeukemiaClinicalStudiesPosterIII">
            <map:grouping-key>Poster Abstracts/613. Acute Myeloid Leukemia: Clinical Studies: Poster III</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies: Poster III</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantationPosterI">
            <map:grouping-key>Poster Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantationPosterII">
            <map:grouping-key>Poster Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantationPosterIII">
            <map:grouping-key>Poster Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts615.AcuteMyeloidLeukemiaCommerciallyavailableTherapyexcludingTransplantationPosterI">
            <map:grouping-key>Poster Abstracts/615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster I</map:grouping-key>
            <map:display-name>615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:display-name location="toc">615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts615.AcuteMyeloidLeukemiaCommerciallyavailableTherapyexcludingTransplantationPosterII">
            <map:grouping-key>Poster Abstracts/615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster II</map:grouping-key>
            <map:display-name>615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:display-name location="toc">615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts615.AcuteMyeloidLeukemiaCommerciallyavailableTherapyexcludingTransplantationPosterIII">
            <map:grouping-key>Poster Abstracts/615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster III</map:grouping-key>
            <map:display-name>615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:display-name location="toc">615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationPosterI">
            <map:grouping-key>Poster Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationPosterII">
            <map:grouping-key>Poster Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantationPosterIII">
            <map:grouping-key>Poster Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisPosterI">
            <map:grouping-key>Poster Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisPosterII">
            <map:grouping-key>Poster Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts618.AcuteLymphoblasticLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisPosterI">
            <map:grouping-key>Poster Abstracts/618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts618.AcuteLymphoblasticLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisPosterII">
            <map:grouping-key>Poster Abstracts/618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts618.AcuteLymphoblasticLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosisPosterIII">
            <map:grouping-key>Poster Abstracts/618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster III</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster III</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts621.HodgkinLymphomaBiologyexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts621.HodgkinLymphomaBiologyexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts621.HodgkinLymphomaBiologyexcludingTherapyPosterIII">
            <map:grouping-key>Poster Abstracts/621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster III</map:grouping-key>
            <map:display-name>621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster III</map:display-name>
            <map:display-name location="toc">621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsPosterI">
            <map:grouping-key>Poster Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster I</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster I</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsPosterII">
            <map:grouping-key>Poster Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster II</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster II</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModelsPosterIII">
            <map:grouping-key>Poster Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster III</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster III</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsPosterI">
            <map:grouping-key>Poster Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster I</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster I</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsPosterII">
            <map:grouping-key>Poster Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModelsPosterIII">
            <map:grouping-key>Poster Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgentsPosterI">
            <map:grouping-key>Poster Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster I</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster I</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgentsPosterII">
            <map:grouping-key>Poster Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster II</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster II</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgentsPosterIII">
            <map:grouping-key>Poster Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster III</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster III</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapyPosterIII">
            <map:grouping-key>Poster Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts632.ChronicMyeloidLeukemiaTherapyPosterI">
            <map:grouping-key>Poster Abstracts/632. Chronic Myeloid Leukemia: Therapy: Poster I</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Therapy: Poster I</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts632.ChronicMyeloidLeukemiaTherapyPosterII">
            <map:grouping-key>Poster Abstracts/632. Chronic Myeloid Leukemia: Therapy: Poster II</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Therapy: Poster II</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts632.ChronicMyeloidLeukemiaTherapyPosterIII">
            <map:grouping-key>Poster Abstracts/632. Chronic Myeloid Leukemia: Therapy: Poster III</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Therapy: Poster III</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Therapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts634.MyeloproliferativeSyndromesClinicalPosterI">
            <map:grouping-key>Poster Abstracts/634. Myeloproliferative Syndromes: Clinical: Poster I</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical: Poster I</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts634.MyeloproliferativeSyndromesClinicalPosterII">
            <map:grouping-key>Poster Abstracts/634. Myeloproliferative Syndromes: Clinical: Poster II</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical: Poster II</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts635.MyeloproliferativeSyndromesBasicSciencePosterI">
            <map:grouping-key>Poster Abstracts/635. Myeloproliferative Syndromes: Basic Science: Poster I</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science: Poster I</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts635.MyeloproliferativeSyndromesBasicSciencePosterII">
            <map:grouping-key>Poster Abstracts/635. Myeloproliferative Syndromes: Basic Science: Poster II</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science: Poster II</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts635.MyeloproliferativeSyndromesBasicSciencePosterIII">
            <map:grouping-key>Poster Abstracts/635. Myeloproliferative Syndromes: Basic Science: Poster III</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science: Poster III</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudiesPosterI">
            <map:grouping-key>Poster Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster I</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster I</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudiesPosterII">
            <map:grouping-key>Poster Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster II</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster II</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudiesPosterIII">
            <map:grouping-key>Poster Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster III</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster III</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts637.MyelodysplasticSyndromesClinicalStudiesPosterI">
            <map:grouping-key>Poster Abstracts/637. Myelodysplastic Syndromes – Clinical Studies: Poster I</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies: Poster I</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts637.MyelodysplasticSyndromesClinicalStudiesPosterII">
            <map:grouping-key>Poster Abstracts/637. Myelodysplastic Syndromes – Clinical Studies: Poster II</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies: Poster II</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts637.MyelodysplasticSyndromesClinicalStudiesPosterIII">
            <map:grouping-key>Poster Abstracts/637. Myelodysplastic Syndromes – Clinical Studies: Poster III</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies: Poster III</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts641.CLLBiologyandPathophysiologyexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts641.CLLBiologyandPathophysiologyexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts642.CLLTherapyexcludingTransplantationPosterI">
            <map:grouping-key>Poster Abstracts/642. CLL: Therapy, excluding Transplantation: Poster I</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts642.CLLTherapyexcludingTransplantationPosterII">
            <map:grouping-key>Poster Abstracts/642. CLL: Therapy, excluding Transplantation: Poster II</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts642.CLLTherapyexcludingTransplantationPosterIII">
            <map:grouping-key>Poster Abstracts/642. CLL: Therapy, excluding Transplantation: Poster III</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapyPosterI">
            <map:grouping-key>Poster Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapyPosterII">
            <map:grouping-key>Poster Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapyPosterIII">
            <map:grouping-key>Poster Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts653.MyelomaTherapyexcludingTransplantationPosterI">
            <map:grouping-key>Poster Abstracts/653. Myeloma: Therapy, excluding Transplantation: Poster I</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts653.MyelomaTherapyexcludingTransplantationPosterII">
            <map:grouping-key>Poster Abstracts/653. Myeloma: Therapy, excluding Transplantation: Poster II</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts653.MyelomaTherapyexcludingTransplantationPosterIII">
            <map:grouping-key>Poster Abstracts/653. Myeloma: Therapy, excluding Transplantation: Poster III</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts661.MalignantStemandProgenitorCellsPosterI">
            <map:grouping-key>Poster Abstracts/661. Malignant Stem and Progenitor Cells: Poster I</map:grouping-key>
            <map:display-name>661. Malignant Stem and Progenitor Cells: Poster I</map:display-name>
            <map:display-name location="toc">661. Malignant Stem and Progenitor Cells: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts661.MalignantStemandProgenitorCellsPosterII">
            <map:grouping-key>Poster Abstracts/661. Malignant Stem and Progenitor Cells: Poster II</map:grouping-key>
            <map:display-name>661. Malignant Stem and Progenitor Cells: Poster II</map:display-name>
            <map:display-name location="toc">661. Malignant Stem and Progenitor Cells: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts661.MalignantStemandProgenitorCellsPosterIII">
            <map:grouping-key>Poster Abstracts/661. Malignant Stem and Progenitor Cells: Poster III</map:grouping-key>
            <map:display-name>661. Malignant Stem and Progenitor Cells: Poster III</map:display-name>
            <map:display-name location="toc">661. Malignant Stem and Progenitor Cells: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">661.%20Malignant%20Stem%20and%20Progenitor%20Cells%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts701.ExperimentalTransplantationBasicBiologyEngraftmentandDiseaseActivityPosterI">
            <map:grouping-key>Poster Abstracts/701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster I</map:grouping-key>
            <map:display-name>701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster I</map:display-name>
            <map:display-name location="toc">701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts701.ExperimentalTransplantationBasicBiologyEngraftmentandDiseaseActivityPosterII">
            <map:grouping-key>Poster Abstracts/701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster II</map:grouping-key>
            <map:display-name>701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster II</map:display-name>
            <map:display-name location="toc">701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts701.ExperimentalTransplantationBasicBiologyEngraftmentandDiseaseActivityPosterIII">
            <map:grouping-key>Poster Abstracts/701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster III</map:grouping-key>
            <map:display-name>701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster III</map:display-name>
            <map:display-name location="toc">701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffectsPosterI">
            <map:grouping-key>Poster Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster I</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster I</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffectsPosterII">
            <map:grouping-key>Poster Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster II</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster II</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffectsPosterIII">
            <map:grouping-key>Poster Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster III</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster III</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts703.AdoptiveImmunotherapyPosterI">
            <map:grouping-key>Poster Abstracts/703. Adoptive Immunotherapy: Poster I</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy: Poster I</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts703.AdoptiveImmunotherapyPosterII">
            <map:grouping-key>Poster Abstracts/703. Adoptive Immunotherapy: Poster II</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy: Poster II</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts703.AdoptiveImmunotherapyPosterIII">
            <map:grouping-key>Poster Abstracts/703. Adoptive Immunotherapy: Poster III</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy: Poster III</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts711.CellCollectionandProcessingPosterI">
            <map:grouping-key>Poster Abstracts/711. Cell Collection and Processing: Poster I</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing: Poster I</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts711.CellCollectionandProcessingPosterII">
            <map:grouping-key>Poster Abstracts/711. Cell Collection and Processing: Poster II</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing: Poster II</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts711.CellCollectionandProcessingPosterIII">
            <map:grouping-key>Poster Abstracts/711. Cell Collection and Processing: Poster III</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing: Poster III</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesPosterI">
            <map:grouping-key>Poster Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster I</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster I</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesPosterII">
            <map:grouping-key>Poster Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicitiesPosterIII">
            <map:grouping-key>Poster Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster III</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster III</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionPosterI">
            <map:grouping-key>Poster Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionPosterII">
            <map:grouping-key>Poster Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitutionPosterIII">
            <map:grouping-key>Poster Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrencePosterI">
            <map:grouping-key>Poster Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrencePosterII">
            <map:grouping-key>Poster Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrencePosterIII">
            <map:grouping-key>Poster Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts731.ClinicalAutologousTransplantationResultsPosterI">
            <map:grouping-key>Poster Abstracts/731. Clinical Autologous Transplantation: Results: Poster I</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results: Poster I</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts731.ClinicalAutologousTransplantationResultsPosterII">
            <map:grouping-key>Poster Abstracts/731. Clinical Autologous Transplantation: Results: Poster II</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results: Poster II</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts731.ClinicalAutologousTransplantationResultsPosterIII">
            <map:grouping-key>Poster Abstracts/731. Clinical Autologous Transplantation: Results: Poster III</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results: Poster III</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts732.ClinicalAllogeneicTransplantationResultsPosterI">
            <map:grouping-key>Poster Abstracts/732. Clinical Allogeneic Transplantation: Results: Poster I</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Poster I</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts732.ClinicalAllogeneicTransplantationResultsPosterII">
            <map:grouping-key>Poster Abstracts/732. Clinical Allogeneic Transplantation: Results: Poster II</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results: Poster II</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts801.GeneTherapyandTransferPosterI">
            <map:grouping-key>Poster Abstracts/801. Gene Therapy and Transfer: Poster I</map:grouping-key>
            <map:display-name>801. Gene Therapy and Transfer: Poster I</map:display-name>
            <map:display-name location="toc">801. Gene Therapy and Transfer: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts801.GeneTherapyandTransferPosterII">
            <map:grouping-key>Poster Abstracts/801. Gene Therapy and Transfer: Poster II</map:grouping-key>
            <map:display-name>801. Gene Therapy and Transfer: Poster II</map:display-name>
            <map:display-name location="toc">801. Gene Therapy and Transfer: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts801.GeneTherapyandTransferPosterIII">
            <map:grouping-key>Poster Abstracts/801. Gene Therapy and Transfer: Poster III</map:grouping-key>
            <map:display-name>801. Gene Therapy and Transfer: Poster III</map:display-name>
            <map:display-name location="toc">801. Gene Therapy and Transfer: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">801.%20Gene%20Therapy%20and%20Transfer%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts802.ChemicalBiologyandExperimentalTherapeuticsPosterI">
            <map:grouping-key>Poster Abstracts/802. Chemical Biology and Experimental Therapeutics: Poster I</map:grouping-key>
            <map:display-name>802. Chemical Biology and Experimental Therapeutics: Poster I</map:display-name>
            <map:display-name location="toc">802. Chemical Biology and Experimental Therapeutics: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts802.ChemicalBiologyandExperimentalTherapeuticsPosterII">
            <map:grouping-key>Poster Abstracts/802. Chemical Biology and Experimental Therapeutics: Poster II</map:grouping-key>
            <map:display-name>802. Chemical Biology and Experimental Therapeutics: Poster II</map:display-name>
            <map:display-name location="toc">802. Chemical Biology and Experimental Therapeutics: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts802.ChemicalBiologyandExperimentalTherapeuticsPosterIII">
            <map:grouping-key>Poster Abstracts/802. Chemical Biology and Experimental Therapeutics: Poster III</map:grouping-key>
            <map:display-name>802. Chemical Biology and Experimental Therapeutics: Poster III</map:display-name>
            <map:display-name location="toc">802. Chemical Biology and Experimental Therapeutics: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsPosterI">
            <map:grouping-key>Poster Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster I</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster I</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsPosterII">
            <map:grouping-key>Poster Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster II</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster II</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditionsPosterIII">
            <map:grouping-key>Poster Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster III</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster III</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions: Poster III</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20III&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions%3A%20Poster%20III</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesPosterI">
            <map:grouping-key>Poster Abstracts/902. Health Services and Outcomes Research – Malignant Diseases: Poster I</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases: Poster I</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases: Poster I</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Poster%20I&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Poster%20I</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="PosterAbstracts902.HealthServicesandOutcomesResearchMalignantDiseasesPosterII">
            <map:grouping-key>Poster Abstracts/902. Health Services and Outcomes Research – Malignant Diseases: Poster II</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases: Poster II</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases: Poster II</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Poster%20II&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases%3A%20Poster%20II</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
    <map:group xml:id="Late-BreakingAbstracts">
        <map:grouping-key>Late-Breaking Abstracts</map:grouping-key>
        <map:display-name>Late-Breaking Abstracts</map:display-name>
        <map:display-name location="toc">Late-Breaking Abstracts</map:display-name>
        <map:group xml:id="Late-BreakingAbstractsLate-BreakingAbstractsSession">
            <map:grouping-key>Late-Breaking Abstracts/Late-Breaking Abstracts Session</map:grouping-key>
            <map:display-name>Late-Breaking Abstracts Session</map:display-name>
            <map:display-name location="toc">Late-Breaking Abstracts Session</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Late-Breaking%20Abstracts%20Session&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Late-Breaking%20Abstracts%20Session</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
    <map:group xml:id="ScientificAbstracts">
        <map:grouping-key>Scientific Abstracts</map:grouping-key>
        <map:display-name>Scientific Abstracts</map:display-name>
        <map:display-name location="toc">Scientific Abstracts</map:display-name>
        <map:group xml:id="ScientificAbstractsArterialandVenousThrombosisCommonMechanismsandClinicalImplications">
            <map:grouping-key>Scientific Abstracts/Arterial and Venous Thrombosis: Common Mechanisms and Clinical Implications</map:grouping-key>
            <map:display-name>Arterial and Venous Thrombosis: Common Mechanisms and Clinical Implications</map:display-name>
            <map:display-name location="toc">Arterial and Venous Thrombosis: Common Mechanisms and Clinical Implications</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Arterial%20and%20Venous%20Thrombosis%3A%20Common%20Mechanisms%20and%20Clinical%20Implications&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Arterial%20and%20Venous%20Thrombosis%3A%20Common%20Mechanisms%20and%20Clinical%20Implications</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsFixingtheBrokenHelixGenomeEditingforDiseaseCorrection">
            <map:grouping-key>Scientific Abstracts/Fixing the Broken Helix: Genome Editing for Disease Correction</map:grouping-key>
            <map:display-name>Fixing the Broken Helix: Genome Editing for Disease Correction</map:display-name>
            <map:display-name location="toc">Fixing the Broken Helix: Genome Editing for Disease Correction</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Fixing%20the%20Broken%20Helix%3A%20Genome%20Editing%20for%20Disease%20Correction&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Fixing%20the%20Broken%20Helix%3A%20Genome%20Editing%20for%20Disease%20Correction</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsGenomicsofDiffuseLargeB-CellLymphoma">
            <map:grouping-key>Scientific Abstracts/Genomics of Diffuse Large B-Cell Lymphoma</map:grouping-key>
            <map:display-name>Genomics of Diffuse Large B-Cell Lymphoma</map:display-name>
            <map:display-name location="toc">Genomics of Diffuse Large B-Cell Lymphoma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Genomics%20of%20Diffuse%20Large%20B-Cell%20Lymphoma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Genomics%20of%20Diffuse%20Large%20B-Cell%20Lymphoma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsGranulocytesandTransfusionBiologyTheGoodandtheBad">
            <map:grouping-key>Scientific Abstracts/Granulocytes and Transfusion Biology: The Good and the Bad</map:grouping-key>
            <map:display-name>Granulocytes and Transfusion Biology: The Good and the Bad</map:display-name>
            <map:display-name location="toc">Granulocytes and Transfusion Biology: The Good and the Bad</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Granulocytes%20and%20Transfusion%20Biology%3A%20The%20Good%20and%20the%20Bad&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Granulocytes%20and%20Transfusion%20Biology%3A%20The%20Good%20and%20the%20Bad</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsImmuneSuppressionandBoneMarrowFailure">
            <map:grouping-key>Scientific Abstracts/Immune Suppression and Bone Marrow Failure</map:grouping-key>
            <map:display-name>Immune Suppression and Bone Marrow Failure</map:display-name>
            <map:display-name location="toc">Immune Suppression and Bone Marrow Failure</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Immune%20Suppression%20and%20Bone%20Marrow%20Failure&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Immune%20Suppression%20and%20Bone%20Marrow%20Failure</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsMyelodysplasticSyndromesBeyondtheKaryotypeandBlastCount">
            <map:grouping-key>Scientific Abstracts/Myelodysplastic Syndromes: Beyond the Karyotype and Blast Count</map:grouping-key>
            <map:display-name>Myelodysplastic Syndromes: Beyond the Karyotype and Blast Count</map:display-name>
            <map:display-name location="toc">Myelodysplastic Syndromes: Beyond the Karyotype and Blast Count</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Myelodysplastic%20Syndromes%3A%20Beyond%20the%20Karyotype%20and%20Blast%20Count&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Myelodysplastic%20Syndromes%3A%20Beyond%20the%20Karyotype%20and%20Blast%20Count</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsNaturalKillerCellTherapeutics">
            <map:grouping-key>Scientific Abstracts/Natural Killer Cell Therapeutics</map:grouping-key>
            <map:display-name>Natural Killer Cell Therapeutics</map:display-name>
            <map:display-name location="toc">Natural Killer Cell Therapeutics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Natural%20Killer%20Cell%20Therapeutics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Natural%20Killer%20Cell%20Therapeutics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsNeutrophilsInnateImmunityandHemostasis">
            <map:grouping-key>Scientific Abstracts/Neutrophils, Innate Immunity, and Hemostasis</map:grouping-key>
            <map:display-name>Neutrophils, Innate Immunity, and Hemostasis</map:display-name>
            <map:display-name location="toc">Neutrophils, Innate Immunity, and Hemostasis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Neutrophils%2C%20Innate%20Immunity%2C%20and%20Hemostasis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Neutrophils%2C%20Innate%20Immunity%2C%20and%20Hemostasis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsPredispositiontoMyeloidNeoplasms">
            <map:grouping-key>Scientific Abstracts/Predisposition to Myeloid Neoplasms</map:grouping-key>
            <map:display-name>Predisposition to Myeloid Neoplasms</map:display-name>
            <map:display-name location="toc">Predisposition to Myeloid Neoplasms</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Predisposition%20to%20Myeloid%20Neoplasms&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Predisposition%20to%20Myeloid%20Neoplasms</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsRNAandRedCellDevelopmentinHealthandDisease">
            <map:grouping-key>Scientific Abstracts/RNA and Red Cell Development in Health and Disease</map:grouping-key>
            <map:display-name>RNA and Red Cell Development in Health and Disease</map:display-name>
            <map:display-name location="toc">RNA and Red Cell Development in Health and Disease</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=RNA%20and%20Red%20Cell%20Development%20in%20Health%20and%20Disease&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">RNA%20and%20Red%20Cell%20Development%20in%20Health%20and%20Disease</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsSlipperySlopeofIronBiology">
            <map:grouping-key>Scientific Abstracts/Slippery Slope of Iron Biology</map:grouping-key>
            <map:display-name>Slippery Slope of Iron Biology</map:display-name>
            <map:display-name location="toc">Slippery Slope of Iron Biology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Slippery%20Slope%20of%20Iron%20Biology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Slippery%20Slope%20of%20Iron%20Biology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsCancerGenomeConundrum">
            <map:grouping-key>Scientific Abstracts/Cancer Genome Conundrum</map:grouping-key>
            <map:display-name>Cancer Genome Conundrum</map:display-name>
            <map:display-name location="toc">Cancer Genome Conundrum</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Cancer%20Genome%20Conundrum&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Cancer%20Genome%20Conundrum</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsStemCellReengineeringRegenerationandRejuvenation">
            <map:grouping-key>Scientific Abstracts/Stem Cell Reengineering, Regeneration, and Rejuvenation</map:grouping-key>
            <map:display-name>Stem Cell Reengineering, Regeneration, and Rejuvenation</map:display-name>
            <map:display-name location="toc">Stem Cell Reengineering, Regeneration, and Rejuvenation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Stem%20Cell%20Reengineering%2C%20Regeneration%2C%20and%20Rejuvenation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Stem%20Cell%20Reengineering%2C%20Regeneration%2C%20and%20Rejuvenation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsStemCellsandAging">
            <map:grouping-key>Scientific Abstracts/Stem Cells and Aging</map:grouping-key>
            <map:display-name>Stem Cells and Aging</map:display-name>
            <map:display-name location="toc">Stem Cells and Aging</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Stem%20Cells%20and%20Aging&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Stem%20Cells%20and%20Aging</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsTheMicrobiomesRoleintheDevelopmentofNormalandAbnormalImmunity">
            <map:grouping-key>Scientific Abstracts/The Microbiome's Role in the Development of Normal and Abnormal Immunity</map:grouping-key>
            <map:display-name>The Microbiome's Role in the Development of Normal and Abnormal Immunity</map:display-name>
            <map:display-name location="toc">The Microbiome's Role in the Development of Normal and Abnormal Immunity</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=The%20Microbiome%27s%20Role%20in%20the%20Development%20of%20Normal%20and%20Abnormal%20Immunity&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">The%20Microbiome%27s%20Role%20in%20the%20Development%20of%20Normal%20and%20Abnormal%20Immunity</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsTheMyelomaNicheandtheImmunobiologyofMyeloma">
            <map:grouping-key>Scientific Abstracts/The Myeloma Niche and the Immunobiology of Myeloma</map:grouping-key>
            <map:display-name>The Myeloma Niche and the Immunobiology of Myeloma</map:display-name>
            <map:display-name location="toc">The Myeloma Niche and the Immunobiology of Myeloma</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=The%20Myeloma%20Niche%20and%20the%20Immunobiology%20of%20Myeloma&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">The%20Myeloma%20Niche%20and%20the%20Immunobiology%20of%20Myeloma</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsTheRegulationofPlateletProductionThrombopoietinandBeyond">
            <map:grouping-key>Scientific Abstracts/The Regulation of Platelet Production: Thrombopoietin and Beyond</map:grouping-key>
            <map:display-name>The Regulation of Platelet Production: Thrombopoietin and Beyond</map:display-name>
            <map:display-name location="toc">The Regulation of Platelet Production: Thrombopoietin and Beyond</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=The%20Regulation%20of%20Platelet%20Production%3A%20Thrombopoietin%20and%20Beyond&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">The%20Regulation%20of%20Platelet%20Production%3A%20Thrombopoietin%20and%20Beyond</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="ScientificAbstractsCutting-EdgeMacrophageBiologyDrivingDevelopmentNurturingNichesControllingContagion">
            <map:grouping-key>Scientific Abstracts/Cutting-Edge Macrophage Biology: Driving Development, Nurturing Niches, Controlling Contagion</map:grouping-key>
            <map:display-name>Cutting-Edge Macrophage Biology: Driving Development, Nurturing Niches, Controlling Contagion</map:display-name>
            <map:display-name location="toc">Cutting-Edge Macrophage Biology: Driving Development, Nurturing Niches, Controlling Contagion</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=Cutting-Edge%20Macrophage%20Biology%3A%20Driving%20Development%2C%20Nurturing%20Niches%2C%20Controlling%20Contagion&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">Cutting-Edge%20Macrophage%20Biology%3A%20Driving%20Development%2C%20Nurturing%20Niches%2C%20Controlling%20Contagion</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
    <map:group xml:id="OnlinePublicationOnlyAbstracts">
        <map:grouping-key>Online Publication Only Abstracts</map:grouping-key>
        <map:display-name>Online Publication Only Abstracts</map:display-name>
        <map:display-name location="toc">Online Publication Only Abstracts</map:display-name>
        <map:group xml:id="OnlinePublicationOnlyAbstracts101.RedCellsandErythropoiesisStructureandFunctionMetabolismandSurvivalExcludingIron">
            <map:grouping-key>Online Publication Only Abstracts/101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron</map:grouping-key>
            <map:display-name>101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron</map:display-name>
            <map:display-name location="toc">101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">101.%20Red%20Cells%20and%20Erythropoiesis%2C%20Structure%20and%20Function%2C%20Metabolism%2C%20and%20Survival%2C%20Excluding%20Iron</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts102.RegulationofIronMetabolism">
            <map:grouping-key>Online Publication Only Abstracts/102. Regulation of Iron Metabolism</map:grouping-key>
            <map:display-name>102. Regulation of Iron Metabolism</map:display-name>
            <map:display-name location="toc">102. Regulation of Iron Metabolism</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=102.%20Regulation%20of%20Iron%20Metabolism&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">102.%20Regulation%20of%20Iron%20Metabolism</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts112.ThalassemiaandGlobinGeneRegulation">
            <map:grouping-key>Online Publication Only Abstracts/112. Thalassemia and Globin Gene Regulation</map:grouping-key>
            <map:display-name>112. Thalassemia and Globin Gene Regulation</map:display-name>
            <map:display-name location="toc">112. Thalassemia and Globin Gene Regulation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=112.%20Thalassemia%20and%20Globin%20Gene%20Regulation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">112.%20Thalassemia%20and%20Globin%20Gene%20Regulation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts113.HemoglobinopathiesExcludingThalassemiaBasicandTranslationalScience">
            <map:grouping-key>Online Publication Only Abstracts/113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science</map:grouping-key>
            <map:display-name>113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science</map:display-name>
            <map:display-name location="toc">113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">113.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Basic%20and%20Translational%20Science</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts114.HemoglobinopathiesExcludingThalassemiaClinical">
            <map:grouping-key>Online Publication Only Abstracts/114. Hemoglobinopathies, Excluding Thalassemia – Clinical</map:grouping-key>
            <map:display-name>114. Hemoglobinopathies, Excluding Thalassemia – Clinical</map:display-name>
            <map:display-name location="toc">114. Hemoglobinopathies, Excluding Thalassemia – Clinical</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">114.%20Hemoglobinopathies%2C%20Excluding%20Thalassemia%20%E2%80%93%20Clinical</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts201.GranulocytesMonocytesandMacrophages">
            <map:grouping-key>Online Publication Only Abstracts/201. Granulocytes, Monocytes and Macrophages</map:grouping-key>
            <map:display-name>201. Granulocytes, Monocytes and Macrophages</map:display-name>
            <map:display-name location="toc">201. Granulocytes, Monocytes and Macrophages</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">201.%20Granulocytes%2C%20Monocytes%20and%20Macrophages</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts203.LymphocytesLymphocyteActivationandImmunodeficiencyincludingHIVandOtherInfections">
            <map:grouping-key>Online Publication Only Abstracts/203.Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections</map:grouping-key>
            <map:display-name>203.Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections</map:display-name>
            <map:display-name location="toc">203.Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=203.Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">203.Lymphocytes%2C%20Lymphocyte%20Activation%20and%20Immunodeficiency%2C%20including%20HIV%20and%20Other%20Infections</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts301.PlateletActivationandBiochemistry">
            <map:grouping-key>Online Publication Only Abstracts/301. Platelet Activation and Biochemistry</map:grouping-key>
            <map:display-name>301. Platelet Activation and Biochemistry</map:display-name>
            <map:display-name location="toc">301. Platelet Activation and Biochemistry</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=301.%20Platelet%20Activation%20and%20Biochemistry&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">301.%20Platelet%20Activation%20and%20Biochemistry</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts302.VascularWallBiologyEndothelialProgenitorCellsandPlateletAdhesion">
            <map:grouping-key>Online Publication Only Abstracts/302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion</map:grouping-key>
            <map:display-name>302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion</map:display-name>
            <map:display-name location="toc">302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">302.%20Vascular%20Wall%20Biology%2C%20Endothelial%20Progenitor%20Cells%20and%20Platelet%20Adhesion</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts311.DisordersofPlateletNumberorFunction">
            <map:grouping-key>Online Publication Only Abstracts/311. Disorders of Platelet Number or Function</map:grouping-key>
            <map:display-name>311. Disorders of Platelet Number or Function</map:display-name>
            <map:display-name location="toc">311. Disorders of Platelet Number or Function</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=311.%20Disorders%20of%20Platelet%20Number%20or%20Function&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">311.%20Disorders%20of%20Platelet%20Number%20or%20Function</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts321.BloodCoagulationandFibrinolyticFactors">
            <map:grouping-key>Online Publication Only Abstracts/321. Blood Coagulation and Fibrinolytic Factors</map:grouping-key>
            <map:display-name>321. Blood Coagulation and Fibrinolytic Factors</map:display-name>
            <map:display-name location="toc">321. Blood Coagulation and Fibrinolytic Factors</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">321.%20Blood%20Coagulation%20and%20Fibrinolytic%20Factors</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts322.DisordersofCoagulationorFibrinolysis">
            <map:grouping-key>Online Publication Only Abstracts/322. Disorders of Coagulation or Fibrinolysis</map:grouping-key>
            <map:display-name>322. Disorders of Coagulation or Fibrinolysis</map:display-name>
            <map:display-name location="toc">322. Disorders of Coagulation or Fibrinolysis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">322.%20Disorders%20of%20Coagulation%20or%20Fibrinolysis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts331.PathophysiologyofThrombosis">
            <map:grouping-key>Online Publication Only Abstracts/331. Pathophysiology of Thrombosis</map:grouping-key>
            <map:display-name>331. Pathophysiology of Thrombosis</map:display-name>
            <map:display-name location="toc">331. Pathophysiology of Thrombosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=331.%20Pathophysiology%20of%20Thrombosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">331.%20Pathophysiology%20of%20Thrombosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts332.AntithromboticTherapy">
            <map:grouping-key>Online Publication Only Abstracts/332. Antithrombotic Therapy</map:grouping-key>
            <map:display-name>332. Antithrombotic Therapy</map:display-name>
            <map:display-name location="toc">332. Antithrombotic Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=332.%20Antithrombotic%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">332.%20Antithrombotic%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts401.BasicScienceandClinicalPracticeinBloodTransfusion">
            <map:grouping-key>Online Publication Only Abstracts/401. Basic Science and Clinical Practice in Blood Transfusion</map:grouping-key>
            <map:display-name>401. Basic Science and Clinical Practice in Blood Transfusion</map:display-name>
            <map:display-name location="toc">401. Basic Science and Clinical Practice in Blood Transfusion</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">401.%20Basic%20Science%20and%20Clinical%20Practice%20in%20Blood%20Transfusion</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts501.HematopoieticStemandProgenitorBiology">
            <map:grouping-key>Online Publication Only Abstracts/501. Hematopoietic Stem and Progenitor Biology</map:grouping-key>
            <map:display-name>501. Hematopoietic Stem and Progenitor Biology</map:display-name>
            <map:display-name location="toc">501. Hematopoietic Stem and Progenitor Biology</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">501.%20Hematopoietic%20Stem%20and%20Progenitor%20Biology</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts503.HematopoiesisEpigeneticTranscriptionalandTranslationalControl">
            <map:grouping-key>Online Publication Only Abstracts/503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:grouping-key>
            <map:display-name>503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:display-name>
            <map:display-name location="toc">503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">503.%20Hematopoiesis%3A%20Epigenetic%2C%20Transcriptional%20and%20Translational%20Control</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts504.HematopoiesisCytokinesSignalTransductionApoptosisandCellCycleRegulation">
            <map:grouping-key>Online Publication Only Abstracts/504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation</map:grouping-key>
            <map:display-name>504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation</map:display-name>
            <map:display-name location="toc">504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">504.%20Hematopoiesis%3A%20Cytokines%2C%20Signal%20Transduction%2C%20Apoptosis%20and%20Cell%20Cycle%20Regulation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts506.HematopoiesisandStemCellsMicroenvironmentCellAdhesionandStromalStemCells">
            <map:grouping-key>Online Publication Only Abstracts/506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells</map:grouping-key>
            <map:display-name>506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells</map:display-name>
            <map:display-name location="toc">506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">506.%20Hematopoiesis%20and%20Stem%20Cells%3A%20Microenvironment%2C%20Cell%20Adhesion%20and%20Stromal%20Stem%20Cells</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts508.BoneMarrowFailure">
            <map:grouping-key>Online Publication Only Abstracts/508. Bone Marrow Failure</map:grouping-key>
            <map:display-name>508. Bone Marrow Failure</map:display-name>
            <map:display-name location="toc">508. Bone Marrow Failure</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=508.%20Bone%20Marrow%20Failure&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">508.%20Bone%20Marrow%20Failure</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts601.ChromosomalRearrangementsandDNARepair">
            <map:grouping-key>Online Publication Only Abstracts/601. Chromosomal Rearrangements and DNA Repair</map:grouping-key>
            <map:display-name>601. Chromosomal Rearrangements and DNA Repair</map:display-name>
            <map:display-name location="toc">601. Chromosomal Rearrangements and DNA Repair</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">601.%20Chromosomal%20Rearrangements%20and%20DNA%20Repair</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts602.DisorderedGeneExpressioninHematologicMalignancyincludingDisorderedEpigeneticRegulation">
            <map:grouping-key>Online Publication Only Abstracts/602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation</map:grouping-key>
            <map:display-name>602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation</map:display-name>
            <map:display-name location="toc">602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">602.%20Disordered%20Gene%20Expression%20in%20Hematologic%20Malignancy%2C%20including%20Disordered%20Epigenetic%20Regulation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts603.OncogenesandTumorSuppressors">
            <map:grouping-key>Online Publication Only Abstracts/603. Oncogenes and Tumor Suppressors</map:grouping-key>
            <map:display-name>603. Oncogenes and Tumor Suppressors</map:display-name>
            <map:display-name location="toc">603. Oncogenes and Tumor Suppressors</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=603.%20Oncogenes%20and%20Tumor%20Suppressors&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">603.%20Oncogenes%20and%20Tumor%20Suppressors</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts604.MolecularPharmacologyDrugResistanceMyeloidDiseases">
            <map:grouping-key>Online Publication Only Abstracts/604. Molecular Pharmacology, Drug Resistance–Myeloid Diseases</map:grouping-key>
            <map:display-name>604. Molecular Pharmacology, Drug Resistance–Myeloid Diseases</map:display-name>
            <map:display-name location="toc">604. Molecular Pharmacology, Drug Resistance–Myeloid Diseases</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=604.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%E2%80%93Myeloid%20Diseases&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">604.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%E2%80%93Myeloid%20Diseases</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts605.MolecularPharmacologyDrugResistanceLymphoidandOtherDiseases">
            <map:grouping-key>Online Publication Only Abstracts/605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases</map:grouping-key>
            <map:display-name>605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases</map:display-name>
            <map:display-name location="toc">605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">605.%20Molecular%20Pharmacology%2C%20Drug%20Resistance%20%E2%80%93%20Lymphoid%20and%20Other%20Diseases</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts612.AcuteLymphoblasticLeukemiaClinicalStudies">
            <map:grouping-key>Online Publication Only Abstracts/612. Acute Lymphoblastic Leukemia: Clinical Studies</map:grouping-key>
            <map:display-name>612. Acute Lymphoblastic Leukemia: Clinical Studies</map:display-name>
            <map:display-name location="toc">612. Acute Lymphoblastic Leukemia: Clinical Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">612.%20Acute%20Lymphoblastic%20Leukemia%3A%20Clinical%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts613.AcuteMyeloidLeukemiaClinicalStudies">
            <map:grouping-key>Online Publication Only Abstracts/613. Acute Myeloid Leukemia: Clinical Studies</map:grouping-key>
            <map:display-name>613. Acute Myeloid Leukemia: Clinical Studies</map:display-name>
            <map:display-name location="toc">613. Acute Myeloid Leukemia: Clinical Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">613.%20Acute%20Myeloid%20Leukemia%3A%20Clinical%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts614.AcuteLymphoblasticLeukemiaTherapyexcludingTransplantation">
            <map:grouping-key>Online Publication Only Abstracts/614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">614.%20Acute%20Lymphoblastic%20Leukemia%3A%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts615.AcuteMyeloidLeukemiaCommerciallyavailableTherapyexcludingTransplantation">
            <map:grouping-key>Online Publication Only Abstracts/615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">615.%20Acute%20Myeloid%20Leukemia%3A%20Commercially%20available%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts616.AcuteMyeloidLeukemiaNovelTherapyexcludingTransplantation">
            <map:grouping-key>Online Publication Only Abstracts/616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">616.%20Acute%20Myeloid%20Leukemia%3A%20Novel%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts617.AcuteMyeloidLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosis">
            <map:grouping-key>Online Publication Only Abstracts/617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:grouping-key>
            <map:display-name>617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:display-name>
            <map:display-name location="toc">617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">617.%20Acute%20Myeloid%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts618.AcuteLymphoblasticLeukemiaBiologyCytogeneticsandMolecularMarkersinDiagnosisandPrognosis">
            <map:grouping-key>Online Publication Only Abstracts/618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:grouping-key>
            <map:display-name>618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:display-name>
            <map:display-name location="toc">618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">618.%20Acute%20Lymphoblastic%20Leukemia%3A%20Biology%2C%20Cytogenetics%20and%20Molecular%20Markers%20in%20Diagnosis%20and%20Prognosis</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts621.HodgkinLymphomaBiologyexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/621. Hodgkin Lymphoma: Biology, excluding Therapy</map:grouping-key>
            <map:display-name>621. Hodgkin Lymphoma: Biology, excluding Therapy</map:display-name>
            <map:display-name location="toc">621. Hodgkin Lymphoma: Biology, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">621.%20Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts622.Non-HodgkinLymphomaBiologyexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/622. Non-Hodgkin Lymphoma: Biology, excluding Therapy</map:grouping-key>
            <map:display-name>622. Non-Hodgkin Lymphoma: Biology, excluding Therapy</map:display-name>
            <map:display-name location="toc">622. Non-Hodgkin Lymphoma: Biology, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">622.%20Non-Hodgkin%20Lymphoma%3A%20Biology%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts623.LymphomaChemotherapyexcludingPre-ClinicalModels">
            <map:grouping-key>Online Publication Only Abstracts/623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models</map:grouping-key>
            <map:display-name>623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models</map:display-name>
            <map:display-name location="toc">623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">623.%20Lymphoma%3A%20Chemotherapy%2C%20excluding%20Pre-Clinical%20Models</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts624.LymphomaTherapywithBiologicAgentsexcludingPre-ClinicalModels">
            <map:grouping-key>Online Publication Only Abstracts/624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models</map:grouping-key>
            <map:display-name>624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models</map:display-name>
            <map:display-name location="toc">624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">624.%20Lymphoma%3A%20Therapy%20with%20Biologic%20Agents%2C%20excluding%20Pre-Clinical%20Models</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts625.LymphomaPre-ClinicalChemotherapyandBiologicAgents">
            <map:grouping-key>Online Publication Only Abstracts/625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents</map:grouping-key>
            <map:display-name>625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents</map:display-name>
            <map:display-name location="toc">625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">625.%20Lymphoma%3A%20Pre-Clinical%20%E2%80%93%20Chemotherapy%20and%20Biologic%20Agents</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts631.ChronicMyeloidLeukemiaBiologyandPathophysiologyexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy</map:grouping-key>
            <map:display-name>631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:display-name location="toc">631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">631.%20Chronic%20Myeloid%20Leukemia%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts632.ChronicMyeloidLeukemiaTherapy">
            <map:grouping-key>Online Publication Only Abstracts/632. Chronic Myeloid Leukemia: Therapy</map:grouping-key>
            <map:display-name>632. Chronic Myeloid Leukemia: Therapy</map:display-name>
            <map:display-name location="toc">632. Chronic Myeloid Leukemia: Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">632.%20Chronic%20Myeloid%20Leukemia%3A%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts634.MyeloproliferativeSyndromesClinicalAbstracts">
            <map:grouping-key>Online Publication Only Abstracts/634. Myeloproliferative Syndromes: Clinical Abstracts</map:grouping-key>
            <map:display-name>634. Myeloproliferative Syndromes: Clinical Abstracts</map:display-name>
            <map:display-name location="toc">634. Myeloproliferative Syndromes: Clinical Abstracts</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=634.%20Myeloproliferative%20Syndromes%3A%20Clinical%20Abstracts&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">634.%20Myeloproliferative%20Syndromes%3A%20Clinical%20Abstracts</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts635.MyeloproliferativeSyndromesBasicScience">
            <map:grouping-key>Online Publication Only Abstracts/635. Myeloproliferative Syndromes: Basic Science</map:grouping-key>
            <map:display-name>635. Myeloproliferative Syndromes: Basic Science</map:display-name>
            <map:display-name location="toc">635. Myeloproliferative Syndromes: Basic Science</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">635.%20Myeloproliferative%20Syndromes%3A%20Basic%20Science</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts636.MyelodysplasticSyndromesBasicandTranslationalStudies">
            <map:grouping-key>Online Publication Only Abstracts/636. Myelodysplastic Syndromes – Basic and Translational Studies</map:grouping-key>
            <map:display-name>636. Myelodysplastic Syndromes – Basic and Translational Studies</map:display-name>
            <map:display-name location="toc">636. Myelodysplastic Syndromes – Basic and Translational Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">636.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Basic%20and%20Translational%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts637.MyelodysplasticSyndromesClinicalStudies">
            <map:grouping-key>Online Publication Only Abstracts/637. Myelodysplastic Syndromes – Clinical Studies</map:grouping-key>
            <map:display-name>637. Myelodysplastic Syndromes – Clinical Studies</map:display-name>
            <map:display-name location="toc">637. Myelodysplastic Syndromes – Clinical Studies</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">637.%20Myelodysplastic%20Syndromes%20%E2%80%93%20Clinical%20Studies</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts641.CLLBiologyandPathophysiologyexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/641. CLL: Biology and Pathophysiology, excluding Therapy</map:grouping-key>
            <map:display-name>641. CLL: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:display-name location="toc">641. CLL: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">641.%20CLL%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts642.CLLTherapyexcludingTransplantation">
            <map:grouping-key>Online Publication Only Abstracts/642. CLL: Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>642. CLL: Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">642. CLL: Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">642.%20CLL%3A%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts651.MyelomaBiologyandPathophysiologyexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/651. Myeloma: Biology and Pathophysiology, excluding Therapy</map:grouping-key>
            <map:display-name>651. Myeloma: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:display-name location="toc">651. Myeloma: Biology and Pathophysiology, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">651.%20Myeloma%3A%20Biology%20and%20Pathophysiology%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts652.MyelomaPathophysiologyandPre-ClinicalStudiesexcludingTherapy">
            <map:grouping-key>Online Publication Only Abstracts/652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy</map:grouping-key>
            <map:display-name>652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy</map:display-name>
            <map:display-name location="toc">652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">652.%20Myeloma%3A%20Pathophysiology%20and%20Pre-Clinical%20Studies%2C%20excluding%20Therapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts653.MyelomaTherapyexcludingTransplantation">
            <map:grouping-key>Online Publication Only Abstracts/653. Myeloma: Therapy, excluding Transplantation</map:grouping-key>
            <map:display-name>653. Myeloma: Therapy, excluding Transplantation</map:display-name>
            <map:display-name location="toc">653. Myeloma: Therapy, excluding Transplantation</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">653.%20Myeloma%3A%20Therapy%2C%20excluding%20Transplantation</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts661.MalignantStemandProgenitorCells">
            <map:grouping-key>Online Publication Only Abstracts/661. Malignant Stem and Progenitor Cells</map:grouping-key>
            <map:display-name>661. Malignant Stem and Progenitor Cells</map:display-name>
            <map:display-name location="toc">661. Malignant Stem and Progenitor Cells</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=661.%20Malignant%20Stem%20and%20Progenitor%20Cells&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">661.%20Malignant%20Stem%20and%20Progenitor%20Cells</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts701.ExperimentalTransplantationBasicBiologyEngraftmentandDiseaseActivity">
            <map:grouping-key>Online Publication Only Abstracts/701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:grouping-key>
            <map:display-name>701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:display-name>
            <map:display-name location="toc">701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">701.%20Experimental%20Transplantation%3A%20Basic%20Biology%2C%20Engraftment%20and%20Disease%20Activity</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts702.ExperimentalTransplantationImmuneFunctionGVHDandGraft-versus-TumorEffects">
            <map:grouping-key>Online Publication Only Abstracts/702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects</map:grouping-key>
            <map:display-name>702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects</map:display-name>
            <map:display-name location="toc">702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">702.%20Experimental%20Transplantation%3A%20Immune%20Function%2C%20GVHD%20and%20Graft-versus-Tumor%20Effects</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts703.AdoptiveImmunotherapy">
            <map:grouping-key>Online Publication Only Abstracts/703. Adoptive Immunotherapy</map:grouping-key>
            <map:display-name>703. Adoptive Immunotherapy</map:display-name>
            <map:display-name location="toc">703. Adoptive Immunotherapy</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=703.%20Adoptive%20Immunotherapy&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">703.%20Adoptive%20Immunotherapy</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts711.CellCollectionandProcessing">
            <map:grouping-key>Online Publication Only Abstracts/711. Cell Collection and Processing</map:grouping-key>
            <map:display-name>711. Cell Collection and Processing</map:display-name>
            <map:display-name location="toc">711. Cell Collection and Processing</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=711.%20Cell%20Collection%20and%20Processing&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">711.%20Cell%20Collection%20and%20Processing</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts721.ClinicalAllogeneicTransplantationConditioningRegimensEngraftmentandAcuteTransplantToxicities">
            <map:grouping-key>Online Publication Only Abstracts/721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities</map:grouping-key>
            <map:display-name>721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities</map:display-name>
            <map:display-name location="toc">721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">721.%20Clinical%20Allogeneic%20Transplantation%3A%20Conditioning%20Regimens%2C%20Engraftment%20and%20Acute%20Transplant%20Toxicities</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts722.ClinicalAllogeneicTransplantationAcuteandChronicGVHDImmuneReconstitution">
            <map:grouping-key>Online Publication Only Abstracts/722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution</map:grouping-key>
            <map:display-name>722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution</map:display-name>
            <map:display-name location="toc">722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">722.%20Clinical%20Allogeneic%20Transplantation%3A%20Acute%20and%20Chronic%20GVHD%2C%20Immune%20Reconstitution</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts723.ClinicalAllogeneicandAutologousTransplantationLateComplicationsandApproachestoDiseaseRecurrence">
            <map:grouping-key>Online Publication Only Abstracts/723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence</map:grouping-key>
            <map:display-name>723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence</map:display-name>
            <map:display-name location="toc">723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">723.%20Clinical%20Allogeneic%20and%20Autologous%20Transplantation%3A%20Late%20Complications%20and%20Approaches%20to%20Disease%20Recurrence</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts731.ClinicalAutologousTransplantationResults">
            <map:grouping-key>Online Publication Only Abstracts/731. Clinical Autologous Transplantation: Results</map:grouping-key>
            <map:display-name>731. Clinical Autologous Transplantation: Results</map:display-name>
            <map:display-name location="toc">731. Clinical Autologous Transplantation: Results</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=731.%20Clinical%20Autologous%20Transplantation%3A%20Results&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">731.%20Clinical%20Autologous%20Transplantation%3A%20Results</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts732.ClinicalAllogeneicTransplantationResults">
            <map:grouping-key>Online Publication Only Abstracts/732. Clinical Allogeneic Transplantation: Results</map:grouping-key>
            <map:display-name>732. Clinical Allogeneic Transplantation: Results</map:display-name>
            <map:display-name location="toc">732. Clinical Allogeneic Transplantation: Results</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">732.%20Clinical%20Allogeneic%20Transplantation%3A%20Results</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts801.GeneTherapyandTransfer">
            <map:grouping-key>Online Publication Only Abstracts/801. Gene Therapy and Transfer</map:grouping-key>
            <map:display-name>801. Gene Therapy and Transfer</map:display-name>
            <map:display-name location="toc">801. Gene Therapy and Transfer</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=801.%20Gene%20Therapy%20and%20Transfer&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">801.%20Gene%20Therapy%20and%20Transfer</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts802.ChemicalBiologyandExperimentalTherapeutics">
            <map:grouping-key>Online Publication Only Abstracts/802. Chemical Biology and Experimental Therapeutics</map:grouping-key>
            <map:display-name>802. Chemical Biology and Experimental Therapeutics</map:display-name>
            <map:display-name location="toc">802. Chemical Biology and Experimental Therapeutics</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">802.%20Chemical%20Biology%20and%20Experimental%20Therapeutics</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts901.HealthServicesandOutcomesResearchNon-MalignantConditions">
            <map:grouping-key>Online Publication Only Abstracts/901. Health Services and Outcomes Research – Non-Malignant Conditions</map:grouping-key>
            <map:display-name>901. Health Services and Outcomes Research – Non-Malignant Conditions</map:display-name>
            <map:display-name location="toc">901. Health Services and Outcomes Research – Non-Malignant Conditions</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">901.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Non-Malignant%20Conditions</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
        <map:group xml:id="OnlinePublicationOnlyAbstracts902.HealthServicesandOutcomesResearchMalignantDiseases">
            <map:grouping-key>Online Publication Only Abstracts/902. Health Services and Outcomes Research – Malignant Diseases</map:grouping-key>
            <map:display-name>902. Health Services and Outcomes Research – Malignant Diseases</map:display-name>
            <map:display-name location="toc">902. Health Services and Outcomes Research – Malignant Diseases</map:display-name>
            <map:url>/search?submit=yes&amp;tocsectionid=902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases&amp;volume=124&amp;issue=21</map:url>
            <map:search-parameters>
                <map:param name="tocsectionid">902.%20Health%20Services%20and%20Outcomes%20Research%20%E2%80%93%20Malignant%20Diseases</map:param>
                <map:param name="volume">124</map:param>
                <map:param name="issue">21</map:param>
            </map:search-parameters>
        </map:group>
    </map:group>
</map:toc-order>